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Abstract
The common human GNB3 825C>T variant, which is present in -50% of the 
world’s chromosomes, has previously been shown to predispose individuals to 
hypertension, cardiac and neural disorders. This variant causes the production of a 
stable and gain of function protein Gp3s- This thesis describes the discovery of a 
novel D153del mutation that produces an unstable, loss of function, protein Gp3oin 
the recessively inherited, retinopathy globe enlarged (rge) chickens. This thesis 
also demonstrates that the normal GP3 downstream phosphorylation signalling 
pathways are significantly altered in a tissue specific manner in rge chicken organs 
and in a human GNB3 825TT lymphoblast cell line. In rge tissues expressing 
Gp3D protein, the cAMP induced GRK2 phosphorylation activity is significantly 
altered. Moreover MAPK1 (ERK2) phosphorylation is significantly decreased 
compared to normal tissues. In contrast human 825TT cell lines expressing the 
Gp3S protein, showed enhanced cAMP induced GRK2 and MAPK (ERK1 and 
ERK2) phosphorylation activity. These results confirm previous findings of 
825C>T Gp3 studies, that GP3S is indeed a hyper-activating structural variant, in 
contrast to the D153del Gp3D is a classical recessively inherited non-functional 
mutation.
Keywords: G-protein; Genetic polymorphism; GTPase; Pharmacogenetics; Splice 
variant; Signal transduction, neurological disorders, hypertension, and Cardiac 
disease
Hemanth Tummala 11 PhD.
ABBREVIATIONS, SYMBOLS AND NOTATIONS
AC
Ag
APP
AChE
BARK/ PARK
BSA
cAMP
cGMP
CNG
CREB
DAG
ENaC
EPAC
ERK1/2
GC
GDP
GIRK
channels
Adenylyl cyclase 
Agonist
Amyloid precursor protein
Acetylchotinesterase
P-Adrenergic receptor kinase
Bovine serum albumin
Adenosine cyclic monophosphate
Guanosine cyclic monophosphate
Cyclic nucleotide-gated
cAMP resposive element binding protein
Diacyglycerol
Epithelial sodium channel
Exchange protein activated by cAMP
Extracellular-signal-regulated kinases 1/2
Guanylyl cyclase
Guanosine diphosphate
G protein regulated rectifier inward potassium
Gp3 - Guanine nucleotide binding protein beta 3
subunit protein
GP3D - Guanine nucleotide binding protein beta 3
subunit protein affected by D153del mutation
Gp3S - Guanine nucleotide binding protein beta 3
subunit splice variant protein
GPCR
GRK2
GTP
©h t
IOD
G protein coupled receptor
G protein coupled receptor kinase 2
Guanosine trisphosphate
Diagram modified by Hemanth Tummala 
Intensity optical density
Hemanth Tummala 12 PhD.
IPs
LCA
MAPK
MW
NeDD4-2
Downregulated 4
NRTK
NO
PDE
PhLP
PI3K
PIP2
PKA
PKG
PLA2
PLC
rge
RGS
SGk
VSCC
V2R
WD
wt
Inositol( 1,4,5)-triphosphate 
Leber congenital amaurosis 
Mitogen-activated protein kinase 
Molecular weight
Neuronally Expressed Developmentally
Non-receptor tyrosine kinases
Nitric oxide
Phosphodiesterase
Phosducin-like proteins
Phosphatidylinositol 3-kinase
Phosphatidyl-inositol(4,5)biphosphat
cAMP-dependant protein kinase
Protein kinase G
Phospholipase A2
Phospholipase C
Retinopathy globe enlarged
Regulators of G protein signaling
Serum and Glucocorticoid-inducible kinase
Voltage sensitive calcium channels
Vasopressin type 2 receptor
Tryptophan-Aspartic acid
Wild type
Hemanth Tummala 13 PhD.
Chapter I
The outcome of am  serious research can onm he to 
mahe two Questionsgrow where onhj one cjrew before....
Thorstein Veblen (1857 - 1929)
Chapter 1
Discovery and characterisation of the novel, pathological GNB3 
mutation (D153del/Gp3D,), in the retinopathy globe enlarged (rge)
chicken
Significance of the topic
Inherited retinal dystrophies are a c o m m o n  cause o f  hum an blindness. T o  date, 16 1 
unique hum an retinal diseases have been m apped to specific c h rom osom al loci and 
the defective genes fo r 1 1 1  o f  these have been identified (H a rto n g  et al 20 0 6 ). 
H o w e v e r , identification o f  the genes u n d e rlyin g  the recessively-inherited diseases 
has tended to lag b e h in d , due to a lack o f  large pedigrees fo r m a p p in g  studies 
(R e tN e t; h ttp ://w w w .sph .u th .tm c.e d u /re tn e t/). Fu rth e rm o re , the d e ve lo p m e n t o f  
specific treatments fo r  these conditions based on the genetic in fo rm a tio n  generated 
has been lim ited in part b y  the lack o f  suitable anim al m odels to test therapies.
In  this project, I  aim ed to characterise the m o lecular defects in a chicken m o del o f  
inherited retinal disease k n o w n  as ‘ retino pathy globe enlarged’ (rge) p rio r to 
id e n tify in g  the analogous hum an p hen otype fo r this c o n d itio n , so that the value o f  
these m odels fo r targeted therapy can be assessed.
T h e  chicken has already p ro ve d  a useful m o de l anim al fo r  the stu dy o f  eye 
d evelop m en t and disease (Ju d g e  S J . 19 9 0 , Sander E J  &  W rid e  M A .  1 9 9 7 , M e y  J  &  
T h a n o s  S . 2000) and also has potential advantages as a clinical anim al m o del 
(S e m p le -R o la n d  et al. 19 9 8 ). C h ic k e n  eyes are large, sim ilar in  size to h u m a n eyes, 
w h ic h  facilitate path olog ical e xam in a tio n  and should s im p lify  the testing o f
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therapies fo r retinal diseases. A l s o , the chicken retina is co n e -d o m in a te d , in 
contrast to the other w id e ly  used anim al m o del the m o u se , w h ic h  has a p rim a rily  
ro d -d o m in ate d  retina. G iv e n  that loss o f  cone -fu nction is the m ost d e b ilitating 
com ponent o f  hu m an retinal degeneration, the study o f  retinal degeneration in 
chickens could m ake a valuable c o ntrib u tio n to the search fo r therapies fo r  these 
diseases.
T h e  rge chicken lines, w h ic h  arose spontaneously in com m ercial chicken stocks, 
w ere o rig in a lly  reported around tw e n ty  years ago and the associated eye defects 
w ere sh ow n to be inherited in a recessive m anner (R a n d a ll &  M c L a c h la n  19 7 9  
P o llo c k , et al. 19 8 2 , C la y to n , et al. 19 8 3 , C u rtis , et al. 19 8 8 , C u rtis , et al. 1 9 8 7 ). 
Since the n, this chicken lines has been m aintained at the R o s lin  Institu te, 
E d in b u rg h . T h e  prospect o f  id e n tify in g  the disease-causing genes in chickens, w ith  
large “ fa m ily ”  sizes o f  50 or m ore p ro g e n y , has recently been sim p lifie d  w ith  the 
publication o f  the chicken genom e and the revelation that its p hysical size is o n ly  a 
third o f  the h u m a n genom e ( H illie r  L W ,  et al. 20 0 4).
Retinopathy globe enlarged (rge).
T h e  rge chicken phe n o type  shares som e features w ith  hu m an pathological m y o p ia  
inclu din g  the presence o f  retinal lesions k n o w n  as “ lacquer cracks”  that exte nd 
fro m  the optic nerve to the p e riph e ry (C u rtis  R ,  et al. 1988 M o n tia n i-Fe rre ira  F ,  et 
al. 20 0 4 ). A ffe c te d  birds have a variable degree o f  v is io n  loss at hatch that 
deteriorates g rad u a lly un til all the birds are fu n c tio n a lly b lin d  b y  30 d a y s. D u r in g  
these deve lo p m e n tal stages there is m in im a l visible retinal a tro p h y tho ugh there is 
photoreceptor d y s fu n c tio n , as dem onstrated b y  abnorm al electroretinogram  ( E R G )
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responses, suggesting that the primary lesion may affect function rather than 
structure, (Curtis R, et al. 1988, Montiani-Ferreira F, et al. 2005) Montiani-Ferreira 
F, et al. 2003). As the disease progresses, there is a generalised thinning of the 
retinal layers as well as globe enlargement ( Fig 1 & 1.1), loss of corneal curvature 
and cataracts in the older birds (Curtis PE, et al. 1987, Curtis R, et al. 1988, 
Montiani-Ferreira F, et al. 2003, Inglehearn CF et al. 2003, Montiani-Ferreira F, et 
al. 2005)
F ig u r e  1 :  P a th o lo g y  o f  rge F i g u r e  1 . 1 :  H is to p a th o lo g y  o f  rge
Fig 1: Phenotype retinopathy globe enlarged (rge) in chickens: [A] left. Globes of an rge 
affected (rge/rge) [LEFT] and [B] left Sighted heterozygote (similar to wild type) Carrier 
(right; rge/+) [RIGHT] chick at 180 days post-hatch. Scale bar represents 1cm and eyes are 
shown at the same level of magnification.(Inglehearn C.F etal 2003).
Fig 1.1: Gradual mislocalisation of opsin in rge+/+ retina was observed in the outer nuclear 
layer (ONL). Picture adapted form (Montiani-Ferrera etal 2005). A and B (top right) 
represent the 13 days old control normal and rge affected retina. C and D (bottom right) 
represent 180 days old the control normal retina and rge. Arrows indicate the mislocation in 
pattern of arrangement of retina in the rge when compared to normal.
Although the eye appears to be the only affected organ in rge homozygote birds, it 
was observed from the mating of a blind male homozygote with three sighted 
heterozygotes that of the 138 surviving offspring, 56 were blind and 82 were
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sighted (M o n tia n i-F e rre ira  F ,  et al. 20 0 5 ). T h is  significant (p = 0 .0 2 6 ) d e via tio n 
fro m  the expected 1 :1  ratio fo r  sim ple recessive inheritance suggested that the rge 
trait m a y  be e m b ry o n ic  lethal in  some b ird s , ye t in birds that su rvive  hatching there 
is no apparent difference in m o rta lity  fro m  norm al birds no r a n y other o b vio u s 
abnorm alities apart fro m  the eyes. A  g enom e-w id e linkage screen identified 
linkage to a 1 3 .7 M b  reg ion on chicken chrom osom e 1 betw een the p o ly m o rp h ic  
m arkers M C W 0 1 12  and L E I 0 1 0 1  ( F ig  2 Ing lehearn , et al. 2 0 0 3 ).
Figure 2: Consensus mapping of rge locus
C * *m m  nap pMftbnfrM)
Fig 2: Consensus Map position of rge linkage studies on chicken chromosome 1 highlighted 
potential candiadate genes such as IMPDH1, GLC1F and USH1E along with GNB3 located in 
this region. Figure adapted and modified HT from Inglehearn et al 2003.
H ig h -re s o lu tio n  g e n o typ in g  was p e rfo rm e d  around the critical rge region using 
p re vio u s ly  uncharacterised m icrosatellite m arkers to na rro w  the interval fro m  
1 3 .7 M b  to a 3 .8 M b  re g io n betw een 6 8 .1 M b  and 7 1 .9 M b  on ch ro m o so m e  1 . T h is  
region spanned the centrom ere and contained 7 3  annotated genes. A  candidate
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gene sequencing approach was pursued and literature search to highlight 
candidates that had been involved in vision research identified several molecules 
including a guanine nucleotide-binding protein (G(33), located at 71.3Mb that had 
previously been implicated in the cone (but not rod) visual transduction pathway 
(Peng YW, et al. 1992).
F i g u r e  3 : S y n te n y  v ie w
G N B 3 IB.32 M M -> ENSGALGOOOOOO14499
[C o n tia V ie w l ( 1 : 8 0 .4 0  M b )
[C o n tig V ie w ]
[M u lt iC o n h g V ie w ]
C D C A 3 16.83 M M - > C D C A3
[C o n tia V ie w l ( 1 : 8 0 . 4 1 M b )
[C o n tig V ie w ]
[M u lt iC o n h g V ie w ]
U S P 5  16.83 M M -> U S P 5
(C on tlaV iew ) ( 1 : 8 0 4 1 M b )
[C o n tig V ie w ]
[M u lt iC o n tig V ie w ]
TPI1 16.85 M M -> TP IS  C H IC K
IC o n tia V ie w l ( 1 : 8 0  4 3  M b )
[C o n tig V ie w ]
[M u lt iC o n tig V ie w ]
R P S R 2  16 R5 M M N o  h o m o lo g u e s  ;
IC o n tia V ie w l
LR R C 23 16 88  M M N o  h o m o lo g u e s  |
IC o n tia V ie w l
E N 0 2  16.89 M M -> E N O G  C H IC K
[C o n tia V iew ] ( 1 : 8 0 .4 4  M b )
[C o n tig V ie w ]
[M u lt iC o n tig V ie w ]
Fig 3: The above Figure shows the latest release 50 of the high level of synteny between genes 
at around 80mb (80.29- 80.44Mb), from the telomere of the short arm of chicken chromosome 
1 and the region of 6.65-6.90Mb from the telomere of the short arm of human chromosome 1 
(http://www.ensembl.org/Homo_sapiens/synteny view?otherspecies=Gallus_gallus;chr=12;loc= 
6893875.5;pre=l).
Following the linkage of the rge gene to this region ,of chicken chromosome 1 
(Montiani-Ferreira, et al. 2003), and the subsequent sequencing of the chicken 
genome (Hillier, et al. 2004), An earlier release of this human/ chicken synteny
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v ie w  was used b y  m y  su pervisor, D r  Le s te r to help id e n tify  candidate genes fo r the 
rge trait ( F ig  3 ). T h is  w as necessary as the chicken genes in  this re g io n had o n ly  
been assigned ensem bl num bers and not the actual gene nam e. F o r  e xam p le  the 
chicken G N B 3  gene, w as at that tim e o n ly  assigned the a m b ig u o u s code 
E N S G A L G 0 0 0 0 0 0 14 4 9 9 . B y  using this synte ny v ie w  the names o f  the chicken 
genes in the linkage region w ere identified b y  lo o k in g  at the syntenic h u m a n genes 
e .g . E N S G A L G 0 0 0 0 0 0 14 4 9 9  =  G N B 3 .
G N B 3  was therefore an o b vio u s candidate gene fo r  the rge p h e n o typ e . A lth o u g h  in 
the retina G N B 3  is cone specific (P e n g , et al. 19 9 2 ), it had p re v io u s ly  been show n 
to be expressed in a w id e  va rie ty o f  other tissues (S u n , et al. 2 0 0 5 ). A n y  m utations 
in G N B 3  m a y  therefore alter signalling p ath w a ys in other no n -re tina l tissues, w ith  
lik e ly  pleitropic effects. In  order to understand these possible alterations in signal 
transduction in both retinal and non-retinal tissues, one first has to understand the 
c o m p le x process o f  G  p rotein signalling.
G proteins: History
T h e  e v o l u t i o n a r y  h ig h ly  conserved group o f  m o lecules, k n o w n  as heterotrim eric 
guanine n u c le o tid e -bin ding  proteins ( G  o r G N  p ro te in s), are k e y  determ inants fo r 
the specificity and tem poral control o f  m a n y  signalling processes in  vertebrates 
(N e v e s , et al. 2 0 0 2 ). M a n y  horm ones, neurotransm itters, c h e m o k in e s, local 
m ediators, and sensory stim uli exert their effects on cells b y  b in d in g  to one o f  the 
865 d iffe re nt seven m em brane receptors, w h ic h  are coupled to such heterotrim eric 
G  proteins ( L o d is h , et al. 2 0 0 7 ). These h ig h ly  specialised transducers can m odulate
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the a ctivity  o f  m u ltip le  signalling p ath w a ys leading to diverse b io lo g ic al responses. 
In  v iv o , specific com binatio ns o f  m a n y  d iffe re n t G a  and G p y  subunits are required 
fo r  connecting in d iv id u a l receptors to signalling p ath w a ys (W e ttschu re ck and 
O ffe rm a n n s . 20 0 5 ). 16 different vertebrate genes have been id e ntifie d  that encode 
fo r G a  subunits, fiv e  genes encode fo r  G p  ( G N B 1 - 5 )  and 12  genes encode fo r G y  
subunits (G a u ta m , et al. 19 9 8 ).
G proteins: Structure and Function
H e te ro trim e ric G  proteins consist o f  three d iffe re n t subunits w h ic h  are associated 
in a basal state to a trim eric c o m p le x , containing a - ( G a ) , p - ( G p )  and y-su b u n it 
( G y )  ( F i g  4 ) . F u rth e rm o re , the G a  subunit is c o va le n tly b o u nd  to a guanosine 
diphosphate ( G D P )  m olecule (L o d is h , et al. 2 0 0 7 ). T h is  c o m p le x represents the G  
protein in its inactive state and can interact w ith  a suitable G  protein coupled 
receptor ( G P C R )  (W ettschure ck and O ffe rm a n n s , 20 0 5 ). U n d e r  this tem porary 
c o n d itio n , G  proteins are linked to the inner face o f  the plasm a m em brane b y  
c o va le n tly bou nd  lip id s , interacting w ith  the G a  and G y  subunits (L o d is h , et al. 
2 0 0 7 ). T h e  basic structure o f  the G p  subunit is com posed o f  tw o  distinct regions as 
fo llo w s : an a m in o -te rm in al a-helical segm ent, fo llo w e d  b y  7  repeating units called 
W D  repeats ( F i g  4 )  (G ra c ia -H ig u e ra , et al. 19 9 8 ).E a c h  W D  co n fig u ra tio n  encloses 
4  antiparallel p strands (G a u ta m , et al. 19 9 8 ). T h e  seven W D  repeats are arranged 
in a ring fo rm  to a prope ller structure w ith  seven blades (G ra c ia -H ig u e ra , et al.
19 9 8 ).
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Figure 4: Structure Heterotrimeric G protein complex
Fig 4: Three dimensional Structure of the apy-coniplex of heterotrimeric G proteins. 
(Gautam et al, 1998.)
F ig u r e  5 : S t r u c t u r e  o f  In d iv id u a l s u b u n its  o f  G  p ro te in  h e te r o tr im e r ic  C o m p le x
Fig 5: Three dimensional structures of heterotrimeric G protein subunits: [LEFT] 
Ga subunit. [MID] G[3 subunit, [RIGHT] Gy subunit. Figure obtained from using by 
modification of 1B9X PDB id in deep view 3D modeller version 3.7
The Gy subunit contains two helices and is bound to the Gpsubunit by forming 
partial coiled structures between helices of each subunit at the N terminus (Fig. 5) 
(Gautam, et al, 1998). Today the exact coupling mechanism between G protein and 
its GPCR, i.e. the way in which ligand-induced conformational change in the
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receptor m olecule results in G  protein a c tiva tio n , is still unclear (W e ttschu re ck and 
O ffe rm a n n s , 20 0 5 ). H o w e v e r , already p ro ve n  is the need o f  all three tig h tly  
coupled subunits as a requirem ent fo r  receptor activatio n o f  a G  p rotein (G a u ta m , 
et al, 19 9 8 ). It has also been discovered that the G p y  heterodim er serves to couple 
G a  to the receptor and also to inh ib it its spontaneous release o f  G D P  ( i .e ., acting as 
a guanine nucleotide dissociation in h ib ito r or “ G D I ”  fo r  G a )  and therefore rem ains 
the G  protein in  its inactive state (S id e ro vsk i and W illa r d , 20 0 5 ).
T h e  basic p rinciple o f  G  protein signalling is sh o w n in F i g  6. In  general the first 
step o f  G  protein activatio n is the b in d in g  o f  a norm al h o rm o n al ligand (e .g . 
epinephrine) o r an agonist (e .g . isoproterenol) to the G P C R  (L o d is h  et a l, 2 0 0 7 ). A s  
a consequence, a c o n fo rm a tio n a l change in the c yto s o l-fa c in g  loops o f  the G P C R  
occurs, that allow s interactions betw een the receptor and the G a  subunit and 
term inates the b in d in g  o f  G a  (L o d is h  et a l, 2 0 0 7 ). T h e  interaction prom otes the 
release o f  G D P ,  w h ic h  gets replaced b y  G T P .  A s  a result o f  G T P  b in d in g , the G a  
subunit changes its c o n fo rm a tio n . T h e  additional b in d in g  o f  the G T P  m olecule 
acquired phosphate (term ed term inal y  phosphate) interacts w ith  backb one am ide 
groups o f  a conserved threonine and glycine residue o f  tw o  p rotein segm ents, 
called sw itch I and I I  (L o d is h  et a l, 2 0 0 7 ). C o n s e q u e n tly , a co n fo rm a tio n a l change 
o f  these segments o ccu r, leading to dissociation o f  the G a  subunit fo r m , the 
activated receptor as w e ll as the |3y c o m p le x , both the G a  subunit and the py 
c o m p le x are n o w  free to m odulate the a c tivity  o f  a va rie ty o f  e ffe c to r target 
proteins, like io n channels o r e n zym e s (L o d is h  et al, 2 0 0 7 and W e ttsc h u re c k and
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Offermanns, 2005). To generalize, the triggered GPCR operates as a guanine- 
nucleotide-exchange factor (GEF) (Lodish et al, 2007).
F i g u r e  6 : B a sic  p rin c ip le  o f  G  p r o te in  s ig n a lin g
Fig 6: G proteins are bound to a 7-transmembrane domain receptor and in an inactive state. 
The binding of an agonist (Ag) to the receptor promotes the release of GDP from the a- 
subunit of the heterotrimeric G protein resulting in the formation of GTP-bound Ga. GTP- 
Ga and GPy dissociate and are able to modulate effector functions. Through an intrinsic 
GTPase activity, GTP is hydrolysed to GDP and inactivates the Ga subunit. The process can 
be accelerated by various effectors as well as by regulators of G protein signalling (RGS) 
proteins. GDP-bound Ga then reassociates with GPy. (Wettschurek and Offermanns, 2005 
and Gautam et al., 1998, modified)
The progress of signal transduction via G proteins is terminated by an intrinsic 
GTPase activity that hydrolyses GTP to GDP. Hence, the y-phosphorus atom of the 
y-phosphate from GTP gets associated with oxygen of a water molecule (Farfel et 
al., 1999). This reaction can only be catalyzed, if the involved atoms are arranged 
precisely to neighbouring amino acids of G a (Farfel et al., 1999). Most alterations
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in these am ino acids have been sh ow n to cause a decreased a b ility  to stabilize the 
arrangements o f  these critical atom s. T h is  results in  the slo w in g  o f  G T P  h yd ro lysis 
and term ination o f  the signal (Fa rfe l et a l., 19 9 9 ). A s  a result, these affected G  
protein show  persistent and defective signalling that u su ally leads to a disease 
(Fa rfe l et a l., 19 9 9 ).
A f t e r  h ydro lysis and co nfo rm a tio na l change, G o t reassociates w ith  the P y -c o m p le x 
and is able to act again w ith  a lig and-activated G P C R .  T h u s , the kinetics o f  the 
h ydro lysis determ ines the tim e o f  the activated state o f  the G  p ro te in . T h is  is also 
influenced b y  e ffe cto r proteins, regulators o f  G  protein signalling ( R G S )  and the 
recently discovered so called G o L o c o  m o tif proteins, w h ic h  help G a  dissociation 
and reassociation to G p y  (S id e ro vsk i and W illa r d , 2005). T h e  b in d in g  o f  the G a  
subunit to its target proteins leads to activation o f  the intrinsic G T P a s e  a c tiv ity . 
T h u s , the target protein acts as a G T P a s e -a c tiv a tin g  protein ( G A P )  (L o d is h  et a l.,
2 0 0 7 ). T h e  R G S  protein su pe rfa m ily m odulate the duration o f  the activated state o f  
G  proteins b y  stim ulating the G T P a s e  a c tivity  o f  G  protein G a  subunits ( F i g  6) 
(G o ld  et a l., 19 9 7 ). A l l  R G S  possesses the characteristic R G S  d o m a in  w h ic h  binds 
to the G a -s u b u n its  ( G o ld  et a l., 1 9 9 7 ) and stabilize particu lar arginine and 
glum atine fingers in the active site o f  G T P a s e  (Fa rfe l et a l., 19 9 9 ). R G S  are 
supposed to p la y  an e m ph asized  role in neuronal signal transduction and its 
regulation ( G o ld  et a l., 1 9 9 7 ).
Gpy subunit Regulation and function
T h e  heterodim eric P y -c o m p le x m odulate an array o f  im po rta nt e ffe c to r p roteins,
inclu din g  e n zym e s like phospholipase A 2 ( P L A 2) w h ic h  is in v o lv e d  in 
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inflammatory response, (3-adrenergic receptor kinase ((3ARK, also called GRK2), 
diverse isoforms of (adenylate cyclase) AC and PLC, and ion membrane carrier 
like potassium, sodium and calcium channels (Ford et al., 1998, Gautam et al., 
1998 and Morishita et al., 1994). The main downstream pathways are summarized 
in Fig 7. Furthermore, free (3y complexes stimulate central and significant 
signalling pathway of the cell which either stand in crosstalk with signalling 
pathways of the Got subunit or appears to be overlapping with them.
F i g u r e  7 :  c A M P  a n d  c G M P  m a in  m essengers in  G  p ro te in  s ig n a llin g  p a th w a y
Fig. 7 -  Main Downstream effector proteins and pathways of the Gocp3y-complex: pathways 
are represented independently of individual effectors regulating through cAMP and cGMP. 
Dotted lines represent secondary messengers activated to regulate downstream effectors. 
Abbreviations: GRK’s - G protein-coupled receptor kinases , cAMP - cyclic adenosine mono 
phosphate, cGMP-cyclic guanine mono phosphate, PKA protein kinase A, PKG protein 
kinase G, PDE phophodiesterases, CNG cyclic nucleotide gated ion channnel MAPK - 
mitogen-activated protein kinase, MEK - MAPK kinase, EPAC exchange protein activating 
cAMP.
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Modulation of effector proteins can occur either in two ways, directly by covalent 
binding events or indirectly through mediator proteins. Functional selectivity of py 
complexes are characterised by a huge diversity and numerous combination 
variants of the diverse G(3- and Gy-Subunits, (Jones et al., 2004). But this diversity 
among various forms of Py complexes seems to be the attribute of the 12 different 
Gy rather than the five different Gp -subunit (Morishita et al., 1994).
Interestingly, downstream targets of G a subunit and Py complex overlap in 
particular cases. For example the isoforms I, II and IV of AC are target proteins of 
diverse compositions of Py complexes and of different Ga subunits. These 
interactions can trigger either negative (e.g. AC I) or positive regulation (e.g. II, 
IV) (Kroetze et al., 2003). Furthermore, isoforms 1 to 3 of PLCp have also shown 
to be activated by particular Py heterodimer compositions (Kroetze et al., 2003, 
Morris, 1997). It has previously been reported that activation PLC occurs by direct 
binding of the PLC catalytic domain to both the N terminus and propeller regions 
of GPy (Bonacci et al., 2005). As it has already proven that the py-complex shows 
equal importance to the G a subunit in maintaining the equilibrium of cell 
physiology, it is not surprising that the significant MAPK-pathways are also 
stimulated by Gpy (Bonacci et al., 2005).
Furthermore, it has been discovered that Gpy directly acts with the Raf-1, a serine/ 
threonine protein kinase and Ras that also represents initiator of MAPK-cascades 
(Ito et al., 1995 and Pumiglia et al., 1995) and in case of over expression influence 
of the phosphorylated state of the MAPK itself (Ito et al., 1995). Additonal proteins
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that directly act with Gpy are calmodulin, dynamin, phosducin, phosducin-like 
proteins (PhLP) and the phosphatidylinositol 3-kinase (PI3K) which is important in 
lipid signalling by providing “docking stations” for target proteins at the 
cytoplasmic membrane (Gautam et al., 1998 and Kroetze et al., 2003). Binding of 
Gpy to dynamin, which is suggested to play a role in synaptic-vesicle recycling, 
leads to its inactivation (Gautam et ah, 1998). In general, it is suggested that 
diverse GPy complexes play significant roles in synaptic signal processing 
(Bertram et ah, 2002).
A further target protein of G proteins with significant importance is beta adrenergic 
receptor kinase (pARK). PARK specifically phosphorylates agonist-occupied 
forms of the P-adrenergic receptor (pAR), as well as the light-bleached form of 
rhodopsin (Benovic et ah, 1987) and is efficiently activated depending on the 
compounds of the heterodimer (Muller et ah, 1993). Binding of GPy in addition 
PIP2 targets pARK to its membrane bound receptor which phosphorylates a certain 
GPCR at particular amino acid residues (Gautam et ah, 1998 and Pitcher et ah,
1995). Phosphorylation of pAR results in desensitization and in particular leads to 
internalization and degradation through P-arrestin binding to this particular kind of 
GPCR and therefore to termination of G protein signalling (Vaughan, et ah, 2006). 
Several lines of evidence have shown that the GPy complex directly covalent binds 
to pARK which leads to activation and subsequently desensitization of musacrinic 
cholingeric and P-adrenergic receptors (Koch et ah, 1993 and Kozasa, 2004).
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Mutations in Gp subunits
Several inherited disorders in vertebrates have been identified in different 
Ga subunits e.g. McCune-Albright syndrome, pseudo-hypoparathyroidism type 
Ia/b, congenital cone dysfunction and night blindness (Reviewed by Weinstein et 
al. 2006). In contrast, before this thesis’s findings (and Tummala et al. 2006) only 
three different vertebrate phenotypes have so far been reported for mutations in the 
GNB proteins, these are outlined in the following paragraphs.
Human 825C>T mutation
The first mutation found was the common GNB3 825C>T mutation, which was first 
reported by Siffert et al. in 1998. This synonymous mutation/variation changes a C 
nucleotide to a T nucleotide at position 825 in exon 10 of GNB3 (825C>T). The 
825C>T mutation paradoxically causes GNB3 exon 9 RNA to misplice approximately 
half the time, deleting 123 nucleotides, causing 41 amino acids to be deleted in the GP3 
protein (Fig 8) and producing the structural variant protein G(33s. (Fig 9). G(33s has a 
structure of circular propeller but with only 6 propeller blades, rather than 7 propeller 
blades. One propeller blade is absent because of the deletion of 41 amino acids (Siffert, 
2000). Gp3S is surprisingly structurally stable and has been postulated to enhance many 
GPCR signalling pathways (e.g.Rosskopf et al., 2003), that the Gp3 protein is involved 
in. Moreover the 825C>T mutation/variation is extremely common in Black Africans 
(e.g. 84% Nigerians studied in the HapMap project have the 825 T/T homozygous 
genotype while 66% of Europeans studied are either 825C/T heterozygous or 825T/T 
homozygous (http://www.hapmap.org/cgi-perl/snp details?name=rs2301339) (Fig 8).
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Figure 8: 825C>T change misplices at Cryptic splice site in GNB3
Fig 8: Gene coding for GNB3 consists of 11 exons with start codon ATG in exon 3 and stop 
codon TGA in exon 11. C to T change at 825th position in exon 10 misplices the gene at cryptic 
splice site at exon 9 there by deleting 123 nucleotides coding to 41 aminoacids (Siffert review 
2000).
Figure 9: Gp3s structure
Fig 9: Gp3 secondary structure consists of 7 propeller structures each on designated as WD 
domain representing propeller. Due the deletion of 41 amino acids caused due to C to T 
change results in deletion of one of the 7 WD domain propellers generating Gj33S structure 
(Siffert review 2000).
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In both these population groups the 825T allele has been shown to be strongly 
associated with Hypertension (e.g. Bagos et al. 2007) and possibly diabetes (e.g. 
Fernandez-Real et al, 2003). The GNB3 825C>T variant is found in at least 30% of 
human chromosomes world wide. The 825T mutation accounts for a major portion 
of worldwide variation in blood pressure and is a major predisposing factor for 
hypertension, low birth weight, obesity, type II diabetes and atherosclerosis in the 
developing world. It has been hypothesised that the GNB3 825T allele probably 
has a selective advantage to people living in equatorial regions, but probably puts 
people at a selective disadvantage to people living in the cold higher latitudes, 
where both salt and calorific intake are generally higher (Young et al 2005).
Figure 10: World wide susceptibility in 825 C>T allele frequency
Fig 10: Figure showing the world wide 825C>T allele frequency (%) distribution and disease 
association such as diabetes hypertension and obesity. Figure obtained from Young etal 2005
It should be noted that to date no association has been made between diabetic (or 
any other retinopathy) and the Gp3 825T mutation (Shcherbak and Schwartz 2001,
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Gao Y et al 1998). This is probably due to the fact that only 40% of the Gp3 genes 
are mis-spliced in the cells of 825T/825T individuals and presumably the 
expression of 60% normal protein is sufficient for continuous, normal retinal 
function (Sun et al 2005).
Gps knockout mice
The second Gp vertebrate mutation that has been reported with a phenotype is the 
Gp5 knockout mouse (Chen et al. 2003), which results in rod dysfunction and a 
“runty” low birth weight phenotype. Moreover 2/3 of GP5 knockout mice die 
before 21 days of infancy, suggesting that these mice may be an animal model for 
some human predisposition to infant death and/or rod dysfunction (e.g. congenital 
stationary night blindness).
GPi Disruption in Mice
A large chromosomal inversion disrupting the Gpi gene in mouse was recently 
identified as the third different phenotype. This mutation is homozygous lethal and 
only viable heterozygotes suffer from inherited retinal degeneration (Kitamura et al 
2006).
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Summary
Following linkage analysis carried out by the Roslin Institute GNB3 (which 
expresses the Gp3 protein), was identified by Dr Douglas H Lester as the prime 
candidate gene for the rge phenotype, using synteny analysis. The Gp3 protein is 
one of five transducin p (p) subunits, which interact with 18 alpha (a) and 12 
gamma (y) subunits that have so far been identified in humans (Downes & Gautam
1999). The diverse combinations of a, P and y, subunits, form a diverse array of 
heterotrimers (and dimers) of guanine nucleotide-binding proteins (G-proteins). 
These diverse combinations of subunits couple the different signal transduction 
processes from the stimulated transmembrane receptors to the downstream 
effectors (Hamm 1998). Mutations and structural variants of the Gp3 protein are 
therefore likely to have pleitropic effects.
For example a GNB3 polymorphism, 825C>T, that causes aberrant splicing in 
some transcripts and subsequent in-frame loss of 41 amino acids, is associated with 
essential hypertension, obesity, coronary heart disease, stroke and diabetic 
nephropathy (Siffert et al. 1998, Siffert 2005). Furthermore, a knockout mouse 
model of the related protein Gp5 has retinal abnormalities and high pre-weaning 
infant mortality (Chen et al. 2003, Krispel et al. 2003), while RNAi knock-down of 
the Gpi orthologue in C.elegans causes 50-80% embryonic lethality and an 
uncoordinated phenotype in the surviving worms (Simmer et al. 2003). These 
observations support the view that GNB protein mutations may have multiple 
deleterious effects.
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It is noteworthy that human G03 had previously been screened in 164 patients with 
various retinal diseases including cone, cone-rod and macular dystrophies, and no 
disease-causing lesions were identified (Gao et al. 1998). One possible reason for 
this may be that the chicken phenotype is more consistent with a severe LCA type 
dystrophy. In addition, since the rge trait appears to be associated with embryonic 
mortality in chickens (Ingleheam et al. 2003), the human counterpart may also 
involve a predisposition to embryonic death leading to miscarriage, making this a 
rare disease or syndrome in surviving patients. On this point the GNB3 825T allele 
has previously been shown to be associated with a decrease in birth weight (Hocher 
et al. 2000).
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Aims and Objectives
The general aim of my thesis was to identify and characterise the pathogenic 
mutation for the cause of the retinopathy globe enlarged (rge) phenotype disease in 
chickens, in the hope of making a discovery with a preferable clinical implication.
The first goal was to identify the underlying pathological mutation in the candidate 
GNB3 gene. Use of the traditional method of exon screening by classical 
sequencing of GNB3 gene was opted for. Any identified mutation would 
subsequently be confirmed due to its segregation with the rge phenotype in a large 
pedigree.
Secondly I set out to investigate the structural affects caused by any identified 
mutation in the Gp3 protein by using insilico secondary structure modelling tools 
such as deep view and What if secondary structure modelling programs.
Thirdly I chose to perform biochemical screening of the mutant Gp3 and its 
downstream effectors and there by attempt to demonstrate the effects of the rge 
mutation in the GP3 protein.
Lastly I aimed to compare the signalling pathways affected by the rge Gp3 
mutation, in different tissues, with the same pathways affected by the human Gp3s 
variant. It was hoped that these experiments would help to prove whether the Gp3s 
is indeed a gain of function variant and to shed light on why humans expressing 
this protein are predisposed to hypertension, Neurological and cardiac disorders.
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Chapter II
The more oriyinaf a discovery, the more obvious it seems 
afterwards..,..
Arthur Koestler (1905 -1983)
Chapter 2
DISCOVERY OF NOVEL D153del MUTATION IN GNB3 GENE 
OF rge DISEASE PHENOTYPE IN CHICKENS
2.1 Introduction
2.1.1 Discovery of D153del in G03 gene
Sequencing of GNB3 gene in wild-type and rge birds identified an in-frame 3bp 
deletion of codon. 153 which segregated with the rge phenotype in all birds tested 
(Fig 11). Deletion of this codon 153 which is an aspartic acid in chicken GNB3 
causes the rge trait. According to the mutation nomenclature criteria by den 
Dunnen and Antonarakis (2001), the mutation is designated as D153del 
Figure 11: Discovery of mutation D153del
Fig 11: GNB3 mutation analysis in wild-type and rge chickens. The lower sequence 
chromatogram illustrates the homozygous D153del GNB3 mutation present in rge chickens. 
The upper image is the corresponding normal sequence
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2.2 Results
2.2.1 D153del Mutation Analysis in rge chicken flocks by per-ARMS 
Amplification Refractory Mutation System test and heteroduplex analysis
system.
Figure 12: PCR-ARMS analysis of the Gp3 mutation D153del in two rge flocks
Fig 12: Lane 1 shows the banding pattern in a White Leghorn (wild-type) bird. Lanes 2 and 
28 represent the asymptomatic heterozygous female parents that give rise to flocks 1 and 2. 
Lane 15 shows the banding pattern of the homozygous D153del male parent of the flocks. 
Lanes 3-8 and 16-21 represent the banding patterns for the asymptomatic offspring from 
flocks 1 and 2 respectively, and lanes 9-14 and 22-27 represent the pattern for the rge affected 
birds. Lane 29 is a no DNA control. This work was done by Dr. Manir Ali at Leeds Univeristy,
Pattern of inheritance for the D153del GNB3 mutation in flocks 1 and 2, appears 
that the D153del allele segregates with the rge phenotype in an autosomal recessive 
manner so that only D153del homozygotes have the disease phenotype (Fig 12 & 
13).This mutation deletes one of two highly conserved aspartic acid residues in the 
GP3 protein causing structural and functional instability.
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Figure 13: Hetero Duplex Analysis for GNB3 Mutation D153del in rge affected
flocks
Fig 13: PCR heteroduplex genotyping of an rge family, using primers specific for GNB3 exon 
6, which includes codon 153. Only unaffected heterozygote chicks show two extra slower 
moving bands characteristic of possessing both a normal and a GNB3 gene containing a 3bp 
deletion in exon 6. All homozygote affected chicks lack any heteroduplex bands, indicates that 
the D153del GNB3 mutation segregates with the RGE trait in this pedigree.
2.2.2 Deletion of Evolutionary Conserved Aspartic acid ‘D’ affects the stable 
Gpy protein secondary structure
Gp3 belongs to a family called WD repeat proteins. WD repeats are highly 
conserved domains of 40-60 aminoacids that start with Glycine-Histidine (GH) 
dipeptide at 11-24 residues from N-terminus and end with a Tryptophan-Aspartic 
acid (WD) dipeptide at the C-terminus. Between GH and WD dipeptides, 
approximately 40 amino acids are conserved. The solved crystal structures of the 
p subunits of heterotrimeric G proteins, including bovine Gpi, have been shown to 
be made up of an amino-terminal cc-helieal segment followed by seven repeating 
units called WD (Trp-Asp) repeats (Smith et al. 1999).
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Figure 14: D153del causes structural defects in Gp3
D153del Missing [3 pleated Sheets
Fig 14: Normal structure of Bos taurus (bt) GJ3| (PDB ID: 1B9XA) showing the standard 
seven propeller structure (Sondek et al 1996), where each propeller domain contains a WD 
repeat motif and consists of 4 anti-parallel beta pleated sheets. A “What IF' prediction of a 
Bos taurus D153del Gfb mutation deletes two beta pleated sheets in propellers 1 and 5 of Gfb 
proteins
As can be seen from (Fig 14) the seven WD repeats in these proteins form seven 
antiparallel (3 sheets which make up the blades of a toroidal propeller structure. The 
mutated aspartic acid residue D153del lies within the variable region II which is 
responsible for the turn between beta sheet a and b in the third propeller of GNB3. 
Although this region in WD proteins is in a so called variable region the sequence 
DDN (where the second D is D153) is very highly conserved in all G(3 proteins as 
evolutionarily conserved amino acid in almost all vertebrate species analysed in 
CLUSTALW alignment program (Fig 15).
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Figure 15: Alignment of the third WD domain of Gp proteins in various 
eukaryotic species using the programme ClustalW
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Fig 15: bt = Bos taurus, ce = Caenorhabditis elegans, cf = Canis faniiliaris, dm = Drosophila 
melanogaster, dr = Danio rerio, fr = Fugu rubripes, gg = Gallus gallus, hs = Homo sapiens, 
mm = Mus musculus, rn = Rattus norvegicus, sc = Saccharomyces cerevisiae, tn = Tetraodon 
nigroviridis, xt = Xenopus tropicalis. The asterix * indicates the position of the highly 
conserved aspartic acid residue at codon 153 in chicken (gg) G(3> Numbers at the end of the 
sequence indicate the accession codes of the sequences used in the analysis.
The structure of Bos taurus GNBl, which is a close homolog of human Gp3, has
been described by (Sondek et al 1996). Modeling the equivalent mutation in Gpi
using the “What If” (Vriend G. 1990) computer programme suggests that this
deletion abolishes beta sheets in propellers 1 and 5 of the Gp protein (appendix
section 7.3 and Fig 14). Further analysis on secondary structure modeling of GPi
molecule resulted in similar structure deleting p pleated sheets in propeller 1 and 5.
(Fig 14). On submitting this structure to the CASP5 committee (Critical Assessment 
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of methods for protein Structure Prediction (Tramontano A 2003), it was predicted 
that this G(3 protein would be unstable and liable to premature proteolysis. This was 
verified by comparing levels of Gp3 protein in retinal cell extracts from wild-type 
and rge birds.
2.2.3 D153del causes Protein haploinsufficiency due to structural instability in 
Gp3
RT-PCR of the GP3 transcript done by our collaborators at Leeds University in a 
range of normal chicken tissues confirmed its ubiquitous expression and relatively 
high expression in the retina, but comparison of the transcript level in normal and rge 
tissues revealed no significant difference(Fig 16).
Figure 16: RT-PCR analysis of Gp3 mRNA expression in multiple chicken
tissues and in normal and rge retinas.
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Fig 16: Lanes 1-10 show the GP3 mRNA expression levels in tissues derived from a normal 
bird. Lanes 11 and 12 show the level of GP3 mRNA expression in the retina of a White 
Leghorn and an rge affected bird respectively. Lane 13 represents the no DNA control.
In contrast a significant decrease in immunoreactive Gp3 protein levels is observed 
in rge tissues compared to normal tissues (Figure 17). This implies that the in silico
modelling of an unstable D153del protein (Figure 14) is likely to be correct. The 
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Gp3D protein is therefore likely to have a much shorter Ubiquitin proteasome, 
degradation half life than normal Gp3 protein (Obin et al 2002) .These results also 
imply that the D153del mutated transcript escapes nonsense mediated decay.
A significant reduction in Gp3 protein immuno reactivity was seen in affected 
retinas when compared to age and sex-matched normal retinas (Fig 17). This drop 
in Gp3 protein level and expression of GP3D protein in rge birds provides further 
proof that D153del is the rge mutation and strongly suggests haploinsufficiency 
due to protein instability as the primary disease mechanism.
Figure 17: D153del mutation causes degradation of Gp3 molecule.
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Fig 17: Western Blot analysis of D153del Gfb affected (rge) and normal tissue (wt) protein 
extracts shows decreased immunoreactivity at 36kDa when blotted against the Leeds 
University Anti- Gp> As a control human CC and TT alleles were analysed to see the 
truncated spliced gene Gp^ s of TT allele caused in Gfb gene due to mutation 825C>T. 
Experiments represent a total of five other trails
In contrast to the unstable mutant chicken Gp3D protein, the common smaller GP3S 
variant protein expressed in the 825TT lymphoblast cell line appears to be equally 
stable to the larger GP3 normal protein, as 2 bands of equal intensity were found on 
Western blotting (Fig 17).
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Figure 18: Densitometry analysis of GNB3 immunoreactivity
Fig 18: Quantitative densitometry analyses proved the lack of Gf^immuno reactivity in the 
D153del affected tissues. Significant fold decrease is observed in D153del affected tissues w hen 
compared to normal. Misplicing ratios 35:65% was observed between Gfb allele and Gfbs 
variant in Human 825TT cell line. Data presented in all panels are the mean with standard 
error (bars) of four or five independent experiments.
These results confirm the findings of Sun et al. 2005, who showed equal intensities 
of RT-PCR bands for both the normal GP3 and Gp3s RNA transcripts in RNA 
extracted from 825TT tissues.
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2.3 DISCUSSION
The in-frame deletion in GP3, designated D153del, deletes one of two highly 
conserved aspartic acid residues in the third of seven WD repeat motifs in the GP3 
protein (Fig 15). The eye phenotype observed shifts interest in Gp3 back towards a 
potential human cone disease phenotype and illustrates the strength of the chicken 
as a model organism for studying inherited human retinal disease, as previously 
suggested (Semple-Rowland and Lee 2000). This finding is the first use of 
Mendelian genetics in chickens to highlight a gene of potential medical 
significance (the mutation responsible for the rd chicken was found using a 
candidate gene approach (Semple-Rowland and Lee 2000). The absence of Gp3 
mutations in cone-rod and macular dystrophy patients in a previous study (Gao et 
al 1998), together with the relatively severe phenotype in the rge chickens, could 
imply a stationary achromatopsia or early onset Lebers amaurosis phenotype. A 
new mutational screen of UK achromatopsia and cone-rod patients is currently 
being carried out by our collaborators, Dr Manir Ali and Prof Chris Inglehearn at 
the University of Leeds.
However the reduced embryonic viability seen in rge chickens, alongside similar 
observations in other Gp mutant animal models (Chen, C.K. et al 2003, Simmer, F. 
et al 2003, ), suggests that GP mutations in humans may also predispose to infant 
mortality and/or pregnancy loss.
A similar outcome has been reported for two drosophila missense mutations in the 
retina specific G-beta protein Gp, both of which cause marked reductions (95% 
and 99.5%) in the amount of protein produced, resulting in a dramatic loss in light
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sensitivity (Dolph PJ 1994). In D153del mutant eye it’s been studied that comeal 
flattening in rge chickens may be related to biomechanical changes caused by 
disarrangement of collagen at the comeal periphery (Boote C 2008). Lack of Gp3 
protein expression level in the retina and sclera explains the regulation of collagen 
content in the eye and the altered molecular modelling of sclera. Both the human 
and chicken Gp3 Western blot results are also consistent with the human Gp3s 
protein being a stable structure, whereas the chicken Gp3D mutant protein as 
previously predicted (Tummala et al 2006) is probably unstable, with a shorter half 
life and probably non or less functional than normal Gp3 protein.
Summary of Chapter 2
This chapter has outlined the successful identification and characterisation at the 
DNA, RNA and protein level, of the D153del Gp3 mutation responsible for the 
retinopathy globe enlarged (rge) phenotype. The following chapters (3 and 4), 
show further biochemical and physiological investigations of the downstream 
pathways affected by both the Gp3Dand Gp3s proteins.
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Chapter III
'Every day you may male proyress. Every step may he 
fruitful, y et there w ill stretch out before you an ever- 
lenytheniny, ever-ascendiny, ever-improviny path, you  
knowyou w ill never y e t to the endofthejoum ey. 'But this, 
so far from discourayiny, only adds to thejoy andylory 
o f the climh..,.
Sir Winston Churchill (1874 -1965)
Chapter 3
Estimation of cAMP and cGMP levels in rge affected tissues to 
identify the molecular defects caused due to D153del mutation
3.1 Introduction
21 human isoforms of PDE that are categorized into 12 families differently 
hydrolyse after activation the cellular concentration of both secondary messengers, 
cAMP and cGMP (Ionita and Pittler, 2007 and Wang et al., 2007). PDE families 4,
7 and 8 possess higher affinity to cAMP than to cGMP and PDE families 5, 6 and 9 
prefer to hydrolyse cGMP (Wang et al., 2007). PDE families 1, 2, 3 and 10 process 
both cAMP and cGMP but also show minor varieties in their efficiency (Wang et 
al., 2007). Alterations in the appropriate ratio of cyclic to hydrolysed form, directly 
affects essential signalling transduction pathways like visual, neuronal or 
transcriptional. Both nucleotide derivates, cAMP and cGMP are important 
mediators of cell signalling and responsible for signal amplification. Thus, the 
following section will provide a brief insight into the central importance of cGMP 
and cAMP with regards to the phototransduction and neuronal transmission 
process.
cGMP, which is synthesized by guanyl cyclase (GC) from guanosine trisphosphate 
(GTP) in response to diverse signals, such as nitric oxide (NO), peptide ligands and 
fluxes in intracellular Ca2+, regulates protein kinases (PKG -  protein kinase G and 
PKA -  protein kinase A with 50 times lower efficiency), directly cyclic nucleotide­
gated (CNG) cation channels and determines its own cellular concentration by 
Hemanth Tummala 45 PhD.
autoregulation due to activation of PDEs (Andreopoulus and Papapetropolous, 
2000 and Lucas et al., 2000).
Figure 19: Visual transduction pathway
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Fig 19: Schematic diagram illustrating mechanisms of activation and inactivation in 
vertebrate photoreceptors. Diagram modified HT from Fain.G.L etal 2001 showing the cone 
cell photoreceptor getting photoactivated and there activating the transducin a  subunit of G 
protein complex. This results in the activation of PDE6 cleaving cGMP to 5’GMP on the cyclic 
nucleotide gated ion channel ( Na+ Ca2+ -K+).
But all of the three target proteins differ in their affinity for cGMP binding, 
dependant to their function in cell physiology. It has been reported that CNG cation
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channels require 10-100 times higher cGMP levels than those needed to activate 
PKG (Fiscus, 2002). cGMP has central importance in diverse physiological 
processes like smooth muscle relaxation, synaptic transmission and retinal signal 
transduction (Andreopoulus and Papapetropolous, 2000).
The main impact of cGMP in human cell physiology is found in the 
phototransduction process. In the outer segments of the rod and cone cells, cGMP 
is responsible for Na+ and Ca2+ flux by modulating CNG cation channels and 
therefore regulates the recovery phase of visual excitations and adaption to 
background light. During dark conditions retinal cells having extremely high basal 
cGMP levels of around 10^10 [iM, which maintain the continuous opening of the 
CNG cation channels (Fiscus, 2002). Light induction leads to rapid hydrolysis of 
cGMP by PDE 6 causing closure of CNG cation channels resulting in 
hyperpolarisation of the rod and cone plasma membrane (Ionita and Pittler, 2007). 
(Ionita and Pittler, 2007). Alteration of cGMP levels in retinal cells have shown to 
result in retinal dystrophies, caused by drastically elevated cytotoxic Ca2+ levels 
(Ionita and Pittler, 2007 and Lucas et al., 2000).
In neuronal cells and many other, cGMP acts through activating PKG. It has been 
discovered that in neuronal signal transduction, stimulated PKG leads to 
phosphorylation of a 23,000-dalton protein (G-substrata) (Fiscus, 2002) which has 
been suggested to effect diverse downstream effector proteins that are involved in 
neuronal transmission.
As already mentioned, glutamatergic signal transduction in neurons is coupled to 
cGMP signaling, where it is mentioned that glutamatergic hypoactivity exists in the
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Alzheimer’s disease brain which may contribute to accumulation of APP and 
impaired neuronal function (Mills and Reiner, 1999). Unfortunately, until today no 
evidence has shown a direct linkage between altered cGMP levels and therefore 
decreased release of glutamate that contributes to Alzheimer’s disease. On the 
contrary, it is suggested that low basal levels of cGMP induces reduced activity of 
PKG, which is partial responsible for neuroprotection and thereby preventing 
stimulation of proapoptotic pathways (Fiscus, 2002).
Like cGMP, cAMP represents as universal messenger and gets regulated in its 
concentration by Adenylyl cyclase (AC) and PDE-isoforms. As mentioned above, 
cAMP is synthesized in cell from ATP by cell membrane bound enzyme Adenylyl 
Cyclase. It is also continuously hydrolysed to Adenosine 5’-monophosphate (5’- 
AMP) by cyclic AMP phosphodiesterases. G proteins are mainly involved in the 
regulation of levels of cAMP in a cell. Even though, a subunit activates adenylyl 
cyclase mostly, (3y dimer is also involved equally in the reaction. Upon activation 
of G protein, activated Ga-GTP binds to Adenylyl cyclase enzyme and regulates 
the synthesis of cAMP. AC after activation through G proteins, which serves as an 
activator for CNG cation channels, the GTP exchange factor EPAC (exchange 
protein activated by cAMP) and mainly PKA. Activated PKA stimulate a huge 
diversity of effector proteins (Patterson, et al., 2000) down stream cAMP 
dependent PKA pathway.
In most of the cells, cAMP shows its effects by activating cAMP dependent 
Protein/phospho Kinase A (PKA), but sometimes it directly activates ion channels 
in plasma membrane.
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PKA activates different substrates in different cells. So, the effects of cAMP vary 
differently based on the type of cell. In inactivated state, PKA has a complex 
structure of two catalytic subunits and two regulatory subunits. Cyclic AMP binds 
to regulatory subunits of PKA and releases the catalytic subunits. The activated 
catalytic subunits phosphorylate specific protein substrate molecules in cell.
Figure 20: cAMP dependent PKA mediated pathway
Fig 20: Activation of Gs-coupled receptors promotes increased AC activity and cAMP 
accumulation. Subsequent PKA activation leads to the activation of the transcription factor 
CREB and effector MAPKs through RAS/RAF pathway. Figure obtained from Wong 2007 
review modified ®HT
The regulatory subunits are also useful in localizing the kinase inside the cell. 
cAMP response elements (CRE) are short DNA sequences that are found in 
regulatory regions of various genes. The cAMP is required to activate these CRE. 
PKA activates CRE-binding (CREB) protein, upon which it binds to CRE along
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with CREB-binding proteins (CBP) and transcribes the genes (Fig 20). Direct 
involvement of Gp3 in controlling cAMP levels have previously shown by Bullido 
et al., (2004). These authors proved that there is a significant increase in cAMP 
levels in a human embryonic kidney cell simultaneously transfected with plasmids 
expressing Gp3s protein and a variant of the p-andrenergic receptor protein, In 
addition other studies have also shown, in several tissues, that the Gp3s protein 
appears to hyperactivate signalling pathways (Siffert W1995, S. Virchow 1999, 
Siffert W & Rosskopf D 1995, Pietruck F 1996, Rosskopf D 1993).
From these previous findings and results I therefore hypothesised that both cAMP 
and cGMP levels would be likely to be significantly altered in both tissues 
extracted from homozygote D153del GP3D chickens and in 825TT Gp3s human cell 
lines.
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3.2 Results
3.2.1 Lack of GP3 protein causes altered adenylyl cyclase activity (cAMP)
An increase in cAMP levels such as 24.04 ±1.2 folds in D153del affected retina
2.17 ± 0.17 folds increases in D153del affected brain was observed (Fig 21). 
Around ~2 fold decrease in cAMP levels was observed in liver kidney and heart 
tissue of rge chickens suggesting the nonfunctional Gpy dimer in regulating Ga 
subunit and failing subsequent down stream effector activation of (AC’s) which 
synthesize cAMP.
Figure 21: Elevated cAMP levels observed in GP3D chicken retina and Human 
TT allele.
Retina Brain Heart Liver Kidney Human
Fig 21: cAMP levels are determined and significant high fold increase around 24.04 ± 1.2 folds 
is found in D153del affected retina and 2.1± folds in brain samples when compared to normal. 
Around 2.17 ± 0.17 folds decrease in cAMP was observed in D153del affected heart sample 
when compared to normal. Human 825TT samples showed significant >5 fold increase of 
cAMP over 825CC allele confirming bullidos work (2004). Data are the mean with standard 
error (bars) of three independent experiments performed in triplicate.
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3.2.2 cGMP analysis key mediator of intracellular signalling in visual 
transduction process
Since cGMP showed a pivotal role as key mediator of intracellular signalling in 
visual transduction process, in addition it also participates highly in synaptic 
signalling and neuronal cell physiology (Fiscus, 2002), cGMP levels were 
determined in retina, brain and heart tissue protein extracts. Both, rge-affected 
brain and retinal cells showed abnormal levels of cGMP. Interestingly, in 
comparison of D153del-affected brain to retinal protein extract a 1.44 ± 0,23 fold 
decrease in cGMP concentration was observed in comparison to normal brain . 
Retinal protein extract of rge-affected chickens showed a significant high fold (2.7 
± 1.27) increase in comparison to normal (Fig 22).
Figure 22: Elevated cGMP levels observed in G03d Chicken Retina and Human
825TT allele
Fig 22: cGMP levels are determined and significant high fold increase around 2.7 ± 1.27 folds 
is found in D153del affected retina and 1.44 ± 0.23 folds decrease in brain samples when 
compared to normal. Interestingly Human 82STT samples showed a significant 4 fold increase 
of cGMP when compared to 825CC samples. Data are the mean with standard error (bars) of 
three independent experiments performed in triplicate.
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3.3 Discussion
3.3.1 Elevation in cAMP level could be an impaired function of the fly-complex 
in neural signalling
cAMP is involved in many signal transmission processes and especially in 
regulation of the hormone-stimulated generation of glucose from glycogen (Lodish 
et al., 2007). Neuronal signalling pathways of cAMP are also significant because 
they are ubiquitous, extremely efficient, versatile, multi modal and have an 
essential role in learning and memory (Mansuy, 2004). Inhibition of a certain Gj 
protein function that normally regulates negatively AC activity has shown to result 
in an increased cAMP level and impairing certain forms of memory, also with 
long-term effects (Mansuy, 2004). In addition to that, it has reported that 
Alzheimer’s is associated with a general elevation in cAMP level (Bullido et al., 
2004) and found to be increased in the cerebrospinal fluid of patients suffering 
from this neurodegenerative disorder (Martinez et al., 1999).
Taking the assumption that due to structural alteration caused by D153del in Gp3 
(Tummala et al 2006), in this particular case, AC as direct downstream effector of 
Ga would be prolonged active and therefore increased synthesis of cAMP occurs. A 
secondary explanation for the elevation in cAMP level could be an impaired 
function of the py-complex.
3.3.2 High toxic levels of cAMP cause of retinal cell disruption in rge 
phenotype
In the cone cells of the homozygous D153del Gp3D chicken, probably less Gtoi2 
subunits will bind to the unstable Gp3o subunit. As photo-activated Gtci2 iS known to
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be an inhibitor of Adenylate cyclase (Wilkie et al., 2007), the production of less 
Gtoi2 will cause the production of more cAMP (Fig 23). High local level cAMP can 
be toxic to photoreceptor cells and become unresponsive to survival factors 
resulting due to altered signalling, and may contribute to retinal cell disruption 
(Traverso, 2002) thereby causing retinal enlargement and leading to progressive 
blindness in these chickens.
3.3.3 Reduced cAMP causes glycogen accumulation in D153del affected tissues
In contrast decreased cAMP levels were observed in D153del affected heart liver 
and kidney tissues when compared to normal (Fig 21). Both the Ga-subunit, the (3y- 
conjugate exert effects to particular AC isoforms, which can be either negative (AC 
I) or positive regulated (II, IV) (Kroetze et al., 2003). This present data should be 
analyzed further in order to investigate the counteract feedback mechanisms 
between Ga-subunit, and the Py-conjugate in regards to the isoforms of Adenylyl 
cyclases (AC I, II, & IV). As reduced levels of cAMP in liver protein samples of 
rge chicks observed suggesting the effect on Glycogenolysis pathway which is 
regulated by cAMP in liver cells (Jiang G and Zhang B. 2003). Also, Borba-Murad 
et al (2004) postulated that the inhibition of glycogen catabolism is associated with 
the reduced levels of cAMP in rat liver cells i.e. with the decrease in levels of 
cAMP in cell; there is a proportionate increase in the levels of glycogen in cell. 
Hence, it can be assumed that there could be an increase in the levels of glycogen 
in liver cells of rge phenotype G03d chicken. There may be a chance of decrease in 
levels of glucose and also equal chances of increase in glucose levels, may be due 
to other factors, in rge phenotype Gp3D chickens. So, there may be some direct or
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indirect correlation of diabetes disorder with the increased levels of glycogen of 
Gp3D chicken.
Also, Montiani-Ferreira, et al (2003) reported a pathological feature of abnormal 
localization and accumulation of glycogen in the peri-nuclear region of 
photoreceptor in rge chicken retina. As the levels of cAMP are low in D153del 
affected Gp3D chickens kidney , the levels of glycogen might increase in these 
cells. This might be the probable explanation of glycogen accumulation in 
photoreceptors, and can be considered as one of the reasons for accumulation of 
glycogen in photoreceptors of rge phenotype Gp3D chickens, which are to be 
confirmed by further experiments.
cAMP activates cAMP response element (CRE), a short DNA sequence that is 
found in regulatory regions of many genes. PKA activates CRE-binding (CREB) 
protein, a specific gene regulatory protein that binds and regulates CRE to 
synthesize renin (Tamura et al, 1994). As the levels of cAMP in kidney Gp3D 
chickens are low, the synthesis of renin may be affected due to lack of 
transcriptional regulation mediated through inadequate cAMP and the 
concentration of renin may decrease in kidney. Increased levels of cAMP will 
increase the transcription of specific genes (Alberts, et al. 2002) and mediate 
several responses like glycogen breakdown (glucagon hormone in liver) 
salt(aldosterone), water reabsorption (vasopressin hormone in kidney), and 
increase in heart rate and force of contraction (adrenaline hormone in heart) 
(Alberts, et al. 2002). In kidney binding of vasopressin on V2R receptor activate 
Gsa adenylyly cyclises to release cAMP (Boone M and Deen PM 2008). Increase
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of cAMP will stimulate the activity of PKA to phosphorylate Nedd 4-2 
(Neuronally Expressed Developmental^ Downregulated 4), a down stream 
mediator down regulates epithelial Na+ transport through inhibition of the epithelial 
sodium channel (ENaC) (Snyder et al 2004). This mechanism of increased cAMP 
and PKA activity increases ENaC activity due to synergistic effects of SGK 
(Bonny O and Hummler E, 2000). Another contributing factor for hypertension 
will be the increased rate of cAMP synthesis activates EPAC pathway which, 
stimulates PI3K effector to cause increased ENaC activity (Helms et al 2006). 
Hypertensive patients carrying TT allele have an increased PKA mediated Na/H 
exchanger (NHE) activity with increased Na+ reabsorption (Siffert 2000). Hence, 
the reduced levels of cAMP in kidney of Gp3D chickens may reduce hypertension 
and blood pressure which, should be confirmed by testing the ENaC activity in 
kidney of the GP3D chickens
3.3.4 cGMP defines the pathogenesis of rge phenotype
Earlier discovery of D153del was found to be responsible for the autosomal 
recessive ocular disease phenotype retinopathy globe enlarged (rge) in chickens 
that causes progressive retinal degeneration and total vision loss (Inglehearn et al., 
2003, Montiani-Ferreira et al., 2003 and Tummala et al., 2006). cGMP plays a 
crucial role as a key mediator of intracellular signalling in visual transduction 
process and has previously shown to be significantly increased in other animal 
models possessing recessively inherited visual transduction mutations (e.g. 
Semple-Rowland 1998). As cGMP, also participates in synaptic signalling and 
neuronal cell physiology, any alterations in levels may also change brain cognition
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(Fiscus, 2002). From figure 22 it can be seen that there is a significant increase in 
cGMP in retinal and and significant decrease in brain tissue. As the unstable Gp3D 
protein is unlikely to form stable heterotrimers with Gta2 and Gy in retinal cones, 
much less or no Gta2 will be photo activated by cone opsin. This Gta2 is 
responsible for activating PDE6; therefore any decrease in its activation will result 
in an increase in cGMP due to less cleavage of this molecule by PDE6 . This 
resultant increase of cGMP through impaired hydrolysis may cause a continuous 
opening of CNG channels and leads to drastically elevated Na+ and Ca2+ flux (Fig 
23). The extremely elevated ion levels contribute primarily to disturbance in vision 
and secondarily, result in retinal dystrophies caused by drastically elevated 
cytotoxic Ca2+ levels (Ionita and Pittler, 2007; Lucas et al., 2000).
To conclude, the increase in retinal cGMP concentration is probably one of the 
most likely causes of the retinopathy/ blindness phenotype in rge chickens. By 
prominent examination in whole brain tissue a general decrease in cGMP level was 
observed. It has previously been shown that the cGMP protein kinase G pathway to 
be important in the regulation of synaptic transmission and plasticity, brain 
development and neuroprotection.
cGMP mediated pathways have also been shown to be functional in glial cells and 
may indicate that they control important glial cell physiology associated with 
neuronal function. (Baltrons et al.2008). In addition it has been suggested that low 
basal levels of cGMP is partially responsible for neuron protection (Fiscus, 2002).
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Figure  23: Downstream  effects o f the D153del G p3D m uta tion
Fig 23: Pathway shows the probable downstream effects of the G ^d mutation in cone retinal 
tissue e.g. brain, where GP*D - G,a2 is exclusive. D153del mutation inhibits the function of 
Gta2 resulting in increase of cAMP and cGMP in retina. Key: (+) indicate more than basal 
fold Due to increased expression/aetivity, (-) less than basal fold due to decreased Expression 
/activity. Dotted arrow represents Phosphorylation and desensitization, AC, adenylyl cyclase; 
Gp, G protein Beta subunit, GPCRs, G protein-coupled receptors; PKA, protein kinase A, 
CNG-ehannel, cyclic nucleotide-gated channel G,a2= Gatransducin subunit.
Interestingly the lymphoblast 825TT cell line had significantly increased (~4 fold) 
cGMP level compared to the 825CC cell line (Fig 22). If this differential of cGMP 
levels also occurs in the brain cells in 825TT individuals, it may help explain their 
predisposition to brain diseases, e.g. Alzheimer’s (Bullido 2004), Major depression 
disorder Lopez-Leon (2008) and appear to have a differential response to drug 
treatments for psychiatric disorders (Anttila S et al. 2006, Prestes AP et al. 2007,
Lee HJ et al. 2004, Muller DJ et al 2005, Schiirks M et al. 2007). Moreover as our 
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unstable Gp3D mutant chicken brains shows a decrease in cGMP levels compared 
to normal Gp3 brains, it is unikely that human brains expressing Gp3s stable protein 
will have the same effect. Further investigations are necessary to determine a 
distinct cerebral pathways affected by the decrease in cGMP level.
Summary of results
From our results in the previous chapters (2 and 3), I have provided further 
evidence that the structural changes in the Gp3s protein cause a gain of function in 
comparison to the normal GP3 protein, as I have clearly demonstrated that the GP3S 
protein is highly stable and cells expressing this protein have increased adenylate 
cyclase activity. In contrast the Gp3D protein is almost certainly unstable causing a 
loss of function. This is demonstrated by both its decrease in immunoreactivity and 
the significant increase in cGMP levels in homozygote D153del GP3 retinal tissue. 
The latter result demonstrates that the PDE6 enzyme is not being sufficiently 
activated by cone alpha transducin (Fig 19) due to the structural alterations in the 
Gp3D protein.
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Chapter IV
HJe advance on ourjoumey onhj when we face our aoaf, 
when we are confdent andhefieve we are(joina to win
Oldti I n
Orison Swett Marden (1850 - 1924)
Chapter 4
D153del mutation causes tissue specific pleiotropic effects affecting 
the phosphorylation target effectors in Gp3 controlled signalling 
pathways in comparison to 825C>T mutation
4.1 Introduction
Despite the evidence for a substantial genetic contribution and population based 
studies to the risk of developing brain disorders, hypertension and coronary heart
disease in humans, the discovery of the Gp3s protein and its involvement in these
disorders has not produced a definitive pathway from genetic mutation to the 
resultant pathology (reviewed by Weinstein 2006). Most papers support a G
protein enhanced signalling hypothesis for Gp3s (reviewed by Dobrev et al. 2000).
As GP3 has previously been shown to bind both Gcti and Gets subunits (Rosskopf et 
al. 2003), the activating Gp3s subunit is likely to show different tissue specific 
effects on signalling pathways, depending on the cellular ratios of these a subunits. 
To back this hypothesis up, Krumins and Gilman (2006), found a reduced 
accumulation of both GoCi and Gots subunits following the RNAi inhibition of 
Gp subunits. Disappointingly very few studies (Siffert 2001) have been carried 
out, at the cellular level, using human organ tissues, such as heart and brain, which
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are likely to have altered signalling pathways in humans expressing the GP3S 
protein.
Understanding the effect of GP3 mutant proteins on signalling pathways in such 
tissues, may help to explain the pathological basis of the many complex disorders 
that 825T Gp3 individuals are predisposed to. Due to the limited access to affected 
human tissues, D153del Gp3 mutant chickens may therefore prove to be a useful 
animal model for clinical studies for GP3 affected pathways. Any alterations in 
tissue specific signalling pathways caused by the Gp3D protein are however, likely 
to have the opposite effect to cells expressing the Gp3s protein, but may still reveal 
the likely method of pathogenesis. In this chapter I therefore aimed to study the 
pleiotropic effects of alterations in Gp3 controlled pathways, such as cAMP 
induced GRK2 pathway involving downstream effector MAPK, in tissues 
previously implicated in GP3 disease association.
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4.2 Results
Immuno Blot Analysis
Our western blot and slot blot studies on various tissue protein extracts (Brain, 
Retina, Heart Liver and Kidney) from D153del affected and normal chicken tissues 
revealed significant signalling affects.
4.2.1 D153del affects the G protein phosphorylation activity of MAPK1 
(ERK2)
This study for the first time demonstrated the multi-step alterations of signalling 
pathways connecting D153del mutant Gp3 subunit to MAPkinases and entire 
cellular phosphorylation activity in chickens, a genetic model for defective G 
protein disorders. Furthermore, the study has revealed significant alterations in 
ERK 2, PARK (GRK2) activity, which is activated promoting Gs-mediated 
stimulation of adenylyl cyclase (Bullido etal 2004) and entire cellular protein 
activity, when compared Human 825C>T. cAMP and cGMP levels are observed to 
relate the level of activity affected by these messengers in signal regulation to 
function of the organ.
I compared the altered signalling effect due to mutations in Human cell line 
825CC, 825TT, chicken normal Gp3 and mutant Gp3D tissue protein extract 
samples from heart, brain and retina were blotted against the anti-MAPK 
phosphorylated and unphosphorylated (abeam biosciences) antibodies in 2jLtg/ml
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concentration with blocking reagent for expression and activity analysis (Fig 24 & 
Fig 25). Anti-MAPK phosphorylated is specific for the active, dually- 
phosphorylated form of MAP kinase and does not recognise the non- 
phosphorylated or the monophosphorylated forms of the MAP kinase molecule. 
Decreased MAPK phospho activity is observed in D153del affected chicken tissues 
and increased phospho activity observed in Human 825TT allele compares to CC 
(Fig 4b) suggesting the evidence of G(33d association in increasing the intracellular 
signal transduction via G protein-coupled receptors (Winfried Siffert 2003). Thus 
Quantitative densitometric analysis showed significant fold decrease of EKR2 in 
D153del affected chicken heart (-1.5 ± 0.2 fold), Brain (-2.1 ± 0.4 fold) and retinal 
(-1.7 ± 0.25 fold) tissues (Fig 26).
Figure 24: D153del exert no effect on Unphosphorylated MAPK molecules
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Fig 24: Western blot analysis of total MAPK (only ERK2 in chickens) for normalisation in 
D153del affected retina brain and heart chicken protein extracts showed no significant changes 
when compared to normal. Human samples CC and TT alleles showed no difference (Both ERK1 
& ERK2). Experiments represent a total of five other trails
Figure 25: Phospho ERK2 decreased in D153del affected tissues
w t rge w t rge w t rge TT CC
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Retina Brain Heart H um an
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Fig 25: Western blot analysis of Phopho ERK2 in D153del affected retina brain and heart
chicken protein extracts showed significant changes w hen compared to normal. Human samples 
TT showed increased MAPK activity (ERK1 + ERK2) when compared CC allele. Experiments 
represent a total of five other trails
Figure 26: Determination of Biochemical activity of Phospho MAPK activity
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Fig 26: Quantitative densitometry analyses proved the lack of Phospho ERK2 immuno 
reactivity in the D153del affected tissues. Significant fold decrease is observed in D153del 
affected tissues when compared to normal. Data presented in all panels are the mean with 
standard error (bars) of four/five independent experiments.
4.2.2 cAMP Induced GRK2 phosphorylation observed in D153del affected 
tissues
Since 825C>T was found to be involved in alteration of P-adrenergic signalling in 
neural (Bullido et al., 2004 and Willeit et al., 2003) and cardiovascular system 
(Jaber et al., 1996) the study examined the pARK (GRK 2) activity.
Figure 27: Tissue specific phosphorylation of GRK2 molecules
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Fig 27: Inimunoblot analysis of D153del affected brain heart and retina protein extracts along 
with human cell extracts. Quantitative densitometry analyses showed significant fold increase 
in the immunoreactivity against the phospho specific GRK2 residue in brain retina and 
human TT allele whereas D153del affected heart tissue showed significant ~2.8 fold decrease 
when compared to normal. Experiments represent a total of three as above trails.
Tissue extracts of D153del mutants showed a significant increase in quantity of 
activated (phosphorylated) pARK molecules. D153del affected Brain showed 1.64 
±0.17 folds increase, and in D153del affected retinal protein extract, a 1.76 ± 0.16 
fold increase of immunoreactivity respectively (Fig 27).
4.2.3 D153del affects whole cellular protein phosphorylation
An insight into the entire cellular status of phosphorylated protein residues, such as 
phosphoserine, -threonine and -tyrosine residues (PSTT) were assessed by slot blot 
analysis. This analysis was preffered due to the low sensitivity of the antibody in 
recognition to the specific PSTT residues. This study revealed an association of 
D153del with alterations in cellular balance of entire PSTT residues. In D153del 
brain around 1.3 ± 0.07 folds and in D153del-mutants retina a significant high (3.9 
± 0,97) folds increase in immuno reactivity of PSTT residues were observed (Fig
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2 8 ). In  h e a r t  a ro u n d  2 .5  ±  1.2 fo ld s  d e c re a s e  in  im m u n o  r e a c t iv i ty  w a s  o b s e rv e d
when compared to normal (Fig 28).
Figure 28: Insight into the entire cellular status of phosphorylated protein 
residues
Fig 28: Slot blot analysis of D153del affected retina and brain protein extracts Quantitative 
densitometry analyses proved significant fold increase in the imniunoreactivity against the 
phospho specific anti-serine, threonine and tyrosine residues where as D153del affected heart 
tissue showed significant fold decrease w hen compared to normal. Experiments represent a 
total of three other trails.
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4.3 Discussion
MAPK has defined central importance in cellular growth, differentiation, survival 
and the pathological effects on various downstream pathways, which lead to 
stimulation or repression (Bando et al., 2006 and Werry et al., 2005). Our study 
proved again that chickens lack expressing mammalian homologue of MAPK 
ERK1 but express ERK2 (Sanghera et al., 1992). Previous studies elucidated the 
G-protein mediated -activated kinase (MAP kinase)coupled signalling profile in a 
mice genetic model showed decrease ERK2 phospho activity causing congestive 
heart failure (CHF) mimicking a similar disease in humans (Kacimi R 2003). In 
contrast there is a significant increase of phospho activity in the human 825TT 
lymphoblast cell line compared with the 825CC cell line. This confirms previous 
evidence of an association of Gp3s and an increase in the intracellular signal 
transduction via G protein-coupled receptors (Siffert 2003, Bullido 2004).
Since 825C>T was found to be involved in alteration of p-adrenergic signalling in 
neural (Bullido et al., 2004 and Willeit et al., 2003) and cardiovascular system 
(Jaber et al., 1996) I examined pARK (GRK 2) activity. GRK2 plays a pivotal role 
in desensitization of its associated GPCR. Recent studies showed that a close 
interaction of GP3Y and PKA is required for efficient receptor desensitization 
(Cong et al., 2001). Moreover, GRK 2 activity was potentiated by decreased ERK 
activity (Pitcher et al., 1999). Thus, the amplified activity of GRK 2 that was 
found in brain and retinal protein extract of GP3D mutants is expected to alter the 
kinetics of (photo-) receptor desensitization and therefore to redundancy of 
activation of PDE6a. In the Gp3D heart tissue GRK2 activity was found to be
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relatively decreased when compared to normal (Fig 27). As GRK2 is a cytosolic 
protein that is recruited to the cell membrane in part by the dissociated Gp3DY 
subunits upon receptor stimulation, lack of Gp3 expression in G^3d heart tissue 
stimulates minute responses in the GRK2 receptor..
The Phosphorylated serine threonine and tyrosine (PSTT) activity which were 
determined by slotblot analysis (Fig 28) correlate with the differential mechanism 
of GRK2 activity in cardiovascular system (Fig 27 pARK activity). The obtained 
data do not aid examining alterations in particular signalling pathways, but instead 
demonstrate the wide range of molecular effects, caused by a single amino acid 
deletion in Gp3 subunit. The changes in protein activity could include phosphatases 
as well as kinases. Thus, Gp3D could not be distinctly characterized as a protein 
that causes exclusively decreasing or increasing effects in the alterations of 
signalling pathways.
Summary and future prospects
This study demonstrates the downstream multi-step alterations caused by the 
multifaceted mutant protein subunit Gp3D. The demonstrated alteration of several 
signalling pathways, which connect to MAP kinases and entire cellular 
phosphorylation in the rge chicken, makes this animal a very useful genetic model 
for defective G protein disorders. These molecular findings suggest that a 
complex interplay exists between the protein targets (MAPK and GRK2) and 
cellular messengers (cAMP and cGMP), due to altered signalling by D153del.
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G P sd m u ta n t c h ic k e n  m a y  b e  a  c o n c lu s iv e  m o d e l fo r  h e lp in g  u n d e rs ta n d
pathogenic disorders caused by 825C>T Gp3 mutation in humans.
Table 1: Tissue Specific Effects caused by D153del
signaling member D lS id ete ffected  tissue C 8 2 5 D  | 
affected cell 
Line j
Retina B ra in  H eart L iver K idney Y oruba ( 
population
Mild type G{33 . . . - . . .
Gp3s not expressed in d ell 53 D -affected  chickens —
phospho-G RK  2 n. d. n.d. -
phospho-M A P K 3 not expressed in chickens —
phospho-M APK  1 n.d. n.d. —
phospho-STT -------  -  - -  n.d. n.d. d
cGMP — — .  s  2: = — |
cAMP + ■ +■ ■ * — — -
Table 1 — Alterations in activity or concentration of particular cell signalling members are
observed in homozygous 825C>T-affected cell lines and different Gfbo affected tissues, 
respectively. G ^ d Mutation significantly decreases immunoreactive Gp* protein in all 
homozygous rge/rge tissues examined. We can also clearly see that the Yoruba Gfb 825TT cell 
line has significant decreased immunoreactivity of GJ^when compared to 825CC cell line 
Symbols: +/- 1-2 fold increase/decrease, ++/-- 2-3 fold increase/decrease, +++/— >3 fold 
increase/decrease, = - no significant changes. Abbreviation: n.d. -  no data
The observed thesis results, which are summarized in Table 1, relate to the level of 
activity affected by the defective Gp3 protein in signal regulation to the function of 
the organ.
Furthermore, the study has revealed significant alterations in ERK 2-, PARK 
(GRK2) activity, which is activated and promotes Gs-mediated stimulation of 
adenylyl cyclase (Bullido et al., 2004) and entire cellular protein activity, when 
compared human 825C>T. The pathway shown in Figure 23 will be involved to a 
greater or lesser extent in disease onset, development and therapeutic control. As
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the Gp3D mutant shows tissue specific signalling effects when compared to 825C>T 
for example the rge affected chickens maintains a lower altered Gp3 signalling with 
decreased intracellular cAMP levels. The D153del mutation may therefore 
interfere with a negative feedback loop in the Gp3 signalling and preserve the 
integrity of the diverse cells in the specific tissues studied in rge mutant chickens. 
Finally, the identification of naturally occurring D153del mutation of Gp3 protein 
has already had major implications for understanding the structure and function of 
Gp3 signaling. But unfortunately, the implications of identifying G protein 
mutations for diagnosis and treatment for G protein disorders are, as yet, rather 
limited. This thesis has however, shown the value of the D153del chicken in 
helping to elucidate the complex tissue specific pathways that are probably 
involved in the predisposition of GNB3 825TT individuals to hypertension, cardiac 
and neural disorders. A critical goal in future studies is to provide molecular 
explanation for these different diseases, which will require comprehensive 
understanding the role of individual G protein subunit regulation on their 
downstream target effectors. This can probably be achieved by identifying the 
ratios of Ga, Gp and Gy individual subunits in each specific tissue. This should 
help reveal the molecular basis of these diseases, as there is no clear evidence of 
single interaction that is responsible for all of these diseases.
This report however, does not rule out indirect effects of the Gp3s on controlling 
ion channel function, many of which are controlled by either cAMP or cGMP. 
Future transfection and electrophysiological experiments using constructs that 
express the Gp3s protein in normal mammalian cells should help prove or disprove
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the importance of this variant protein to ion channel function. In vivo studies 
should also be explored to know the mechanism of such interactions. For example 
D153del and 825C>T knock-in genetically engineered mice would be extremely 
useful animal models to try to further elucidate the pathways involved in the early 
stages of disease associated biochemical systems in 825C>T affected individuals.
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Chapter V
Otis common seme to tafe a methodandtry it. Ofit fads, 
admit it franhfy and try another. 'But above a ff try
somethiny.
Franklin D. Roosevelt (1882 - 1945)
Chapter 5
MATERIALS AND METHODS
5.1 Genotyping and identification of candidate gene
High-resolution genotyping was performed using previously uncharacterized 
microsatellite markers that have been downloaded as simple repeat sequences from 
the chicken genome database at UCSC (http://www.genome.ucsc.edu/). Primer 
sequences for the PCR were designed using the Primer3 program 
(http://frodo.wi.mit.edu/cgi-bin/primer3/). The primers were labelled with one of 
the dyes, FAM, HEX or TET (Invitrogen). For the PCR, initial optimisation was 
followed by analysing the markers in the parent DNA to check for informativity. 
Only the polymorphic markers were amplified using the progeny DNA as template. 
For genotyping, the PCR products were migrated through a polyacrylamide gel on 
the ABI377 gene sequencer (Applied Biosystems) and fragment length analysis 
was carried out using the Genescan V. and Genotyper V. softwares. Refinement of 
the rge critical interval was achieved by following the segregation pattern of the 
polymorphic markers with the disease phenotype.
5.2 Sequencing
Genomic DNA was extracted from normal and rge affected bloods using DNAzol 
solution (Invitrogen). 50ng of this Genomic DNA was then added to 12.5ul of 2 X 
master mix solution (Promega) for each 25pl PCR reaction. The intronic flanking
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p r im e rs  ( l p M o f  e a c h ) , u se d  fo r  P C R  a m p lif ic a t io n  o f  all e x o n s , o f  th e  c h ic k e n
GNB3 gene were
GNB3EXl-seqF CTTTCTACCTCTCATCAG 
GNB3EX1F TTGAGCAGTCCTATTGTTGGC 
GNB3EX1R TTTAGAGGGCTGTACGGTGCT
GNB3EX2-seqF ACAAACTAAGCAAAACTC 
GNB3EX2F ATGCCTTGTGCTGGGTACAAT 
GNB3EX2R ACAATCTGAGGAAAGAGCAGG
GNB3EX3-4-seqF CAGGTTGGAAGCAGTTAG 
GNB3EX3-4F ATCACTTCCAAGGGGACTCTC 
GNB3EX3-4R AAAGGGATGGCATGAACCTG
GNB3EX5-6-seqF CCCGCTCTCCTATCTACT 
GNB3EX5-6F ATGCAGGATTGGAACCCTTCA 
GNB3EX5-6R TGAGATCACACAGCACCCTGA
GNB3EX7-seqF TACCCAGGCCCATGACTT 
GNB3EX7F ATGTGGTACCCAGGCCCAT 
GNB3EX7R TTCGTTCCTCCCGGACTCAA
GNB3EX8-seqF CACCCAGGAAGCACGTAT 
GNB3EX8F TTGATTTTTGCTCTGGGGGT 
GNB3EX8R GGAAGAATTGCTGAGTTTTGG
GNB3EX9-seqF CAGAATGATGCACAAGAG 
GNB3EX9F TTGCTAATCACATTTTGCAGG 
GNB3EX9R TGTGTGTACTCCCCCTCCTT
PCR was performed for 30 cycles at 94°C for 30 seconds, 55l’C for 30 seconds and 
72°C for 30 seconds. The reaction products were visualised following agarose gel 
electrophoresis under ultraviolet illumination. QIAquick PCR Purification Kit 
(Qiagen) was used to clean up PCR fragments generated and remove 
unincorporated primers. lOng of cleaned PCR product, together with 3.2 
micromoles (per reaction) of the forward or revere GNB3 primers or an internal 
sequencing primer, were sent to The Sequencing Service, School of Life 
Sciences,University of Dundee (http://www.dnaseq.co.uk/) for commercial 
sequencing.
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5.3_Heteroduplex Analysis
H e te ro d u p le x analyses m ethod is p o p u lar electrophoretic m e thod fo r  identifiaction 
o f  m utated sequence. T e c h n ic al sim p lic ity and relative h igh  se nsitivity has enabled 
us to carry this e xpe rim e nt fo r the detection m utated G N B 3  sequence. T h e  P C R  
a m p lifie d  D N A  fo rm  norm al and rge samples w ere subjected to heteroduple x 
a nalysis., T h e  P C R  produ ct was heated fo r lO m in u te s at 9 5 °C  fo r  10  m inutes and 
im m e d ia te ly cooled on ice before m ix in g  w ith  6X  D N A  lo a d in g  b u ffe r. T h e  
samples w ere then loaded on a 1 0 %  p o lya c ryla m id e  gel w h ic h  is m ade fro m  4 0 %  
stock solution containing 4 0 %  acrylam ide and 0 .4 %  N , N ’ -
m e thylen eb isacrylam id e. G e ls  w ere run at ro o m  tem perature 0 .6 x  T B E  w ith  7 .5  p i 
aliqu ot o f  P C R  products obtained after clean up process m ix e d  w ith  equal am ount 
o f  load ing  b u ffe r un til fragm ents m igrated at least 25 cm . G e ls  w ere stained in gel 
red (sigm a) and photographed under U V  lig h t
5.4 PCR-ARMS Analysis
T h e  P C R  was carried out using the P C R x  En h a n c e r K i t  (In v itro g e n ) w ith  1 x  
enhancer so lu tio n , 1 x  a m p lifica tio n b u ffe r and 1 .5 m M  M g S 04  as w e ll as 0 .2 m M  
d N T P s  and 2 .5 U  T a q  D N A  p olym erase fo r  each lO p l reaction. T h e  oligonu cleotide 
prim ers used in  the reaction w ere d G C A G G G A A C T C T C A G C T C A T A  and either 
(i) d A G C T A G T C A C A A T A C T G T T G T G A T C  (w ild -ty p e ) or (ii) 
d A G C T A G T C A C A A T A C T G T T G T G A A G  (m u tant) to g ive  reaction products o f  
1 7 5  and 1 7 2  bp  respectively. 20 ng D N A  w as used as a tem plate fo r  each reaction 
w h ic h  w as p e rfo rm e d  fo r 30 cycles at 9 4 °C  fo r 30 seconds, 6 1 ° C  fo r  30 seconds
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and 72°C for 30 seconds. The reaction products were visualised following agarose 
gel electrophoresis under ultraviolet illumination.
5.5 Bioinformatics
Multiple sequence alignments were carried out using ClustalW, available through 
http://www.ebi.ac.uk/clustalw/index.html. Clustal W alignments were viewed 
using Jalview and saved in MSF format. The generated MSF file was then opened 
in GENDOC, available through http://www.psc.edu/biomed/genedoc/. Selected 
blocks of the generated alignment were then saved in rtf format and edited in 
Microsoft Word.
5.6 RT-PCR Analysis
Reverse-transcription of chicken RNA that had been isolated from various tissues 
was performed using oligo (dT)i5 primer and Superscript II reverse-transcriptase 
(Invitrogen). Amplification of 3720p of GNB3 cDNA was carried out using the 
primers dCTGGTCAGTGCCTCACAAGA and
dGGGAAACTGCCAAGCTCATA. As normalisation control, amplification of 
237bp of GAPDH (glyceraldehyde 3-phosphate dehydrogenase) was performed 
using the primers dGGAAAGTCATCCCTGAGCTG and 
dCATCAAAGGTGGAGGAATGG.
5.7 Structural Prediction
The D153del GNB3 mutation was modelled in the homologous Bos Taurus GNB-1 
(1B9X) protein, using the both the Deepview (http://spdbv.vital-it.ch/) and the
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5.8 Protein Extraction
T h e  protein extraction was pe rfo rm e d  in regard to B iosou rce tissue extraction 
p rotocol (h ttp ://w w w .b io s o u rc e .c o m , catalog nu m b er: F N N 0 0 7 1 ) .
1 . Tissu e  samples o f  norm al and rge-affected birds (chicken lines: w t -  1 0 1 1 , 
rge -  10 0 5 , R o s lin  Institute) w ere w eighted and placed in  tissue extraction b u ffe r 
(Pierce B io te c h n o lo g y ) containing a protease and phosphatase in h ib ito r cocktail 
(Pierce B io te c h n o lo g y ) at a concentration o f  10 m l extraction b u ffe r fo r each g o f  
tissue. Su bse qu e ntly, tissue samples w ere h o m o g e n ize d  b y  g rin d in g . C e ll extract 
was centrifuged at 10 ,0 0 0  R P M  fo r 5 m inutes to pellet the tissue debris. 
Supernatant were collected, aliquoted and stored at -8 0 ° C .
2 . H u m a n  transform ed B -ly m p h o c y te  cell lines, w ith  k n o w n  G N B 3  825 
genotypes (h ttp ://w w w .n c b i.n lm .n ih .g o v/S N P /sn p _ s s.c g i? s s= ss 6 9 0 9 9 8 6 9 ) ; 8 2 5 C C  
( G M 1 9 1 16 ) and 8 2 5 T T  ( G M 18 5 0 0 ) w ere obtained fro m  C o rie ll C e ll R e p o sito rie s, 
U S A .  These cell lines w ere cultured in 1 0 %  F C S  D M E M  m e dia (S ig m a ) in culture 
flasks and w ere harvested after 48hrs. T h e  m edia containing cells w ere centrifuged 
at 2500g fo r 5 m in  and the pellet was w ashed tw ice w ith  ice cold  P B S  and 
centrifuged again at 2500g fo r  5 m in . 1 m l o f  R I P A  b u ffe r was added fo r 4 0  m g  o f  
w e t cell pellet, m ixe d  w e ll and w ere then sonicated fo r  tw o  cycles 5 seconds at 
5 0 %  pulse. T h e  fin a l m ixtu re  was shaken g e n tly on ice fo r  15 m in  and the Pro te in 
supernatant was obtained b y  ce ntrifu gin g  the cells at 14 0 0 0 g  fo r 15 m in . 
Su bseque ntly all protein extract samples w ere qu an tified w ith  the use o f  a 
spectrophotom eter, w ith  B S A  as a standard.
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5.9 Protein Quantification
T h e  protein qu an tification o f  the extracts w ere carried-out in regard to B ra d fo rd  
standard p rotocol w ith  Coom assie (B ra d fo rd ) Pro te in A s s a y  K i t  (Pierce 
B io te c h n o lo g y ). Pro te in  extract w ere photom etrical a n a lyze d  w ith  the use o f  a 
spectrophotom eter at a w a ve le n gth  o f  595 n m , w ith  B S A  (Pierce B io te c h n o lo g y ) as 
a standard.
5.10 Immunoblotting
5.10.1 Western Blotting
F o r  W estern b lo ttin g , W estern B re e ze  Im m u n o d e te c io n  K i t  (In v itro g e n ) w ere 
e m p lo y e d , fo llo w in g  standard m ethods.
1 . Pro te in extract o f  norm al and rge-affected chickens was electrophoretic 
separated b y  a 1 0 %  B is -T r is  gel (In v itro g e n ).
2 . G e l was placed into  transfer b u ffe r (In v itro g e n ) and transferred to a 
nitrocellulose m em brane (A m e rs h a m  pharm acia).
3. Proteins w ere blotted b y  4 5 V  fo r  45 m in u te s.
4 . M e m b ra n e  was fu rth er processed b y  incu bation w ith  b lo c k in g  solution 
(contents v ie w  chapter 7 . 1 . 1 )  fo r 30 m inutes at ro o m  tem perature on a rotary 
shaker
5. S u bse qu e ntly, m em brane was w ashed 2 tim es fo r 5 m inutes w ith  u ltra pure 
w ater and incubated fo r  2 hours b y  ro o m  tem perature o n a ro ta ry shaker b y  
lO O rp m  w ith  p rim a ry  a n tib o d y o f  interest diluted in b lo c k in g  solution
6 . A ft e r  in c u b a tio n , m em brane was 4  tim es w ashed fo r  each 5 m inutes w ith  
a n tib o d y w ash so lution (In v itro g e n ) and incubated fo r  2 hours at 3 7 ° C  in
secondary a n tib o d y so lution (In v itro g e n ) on ro ta ry shaker.
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7 .  A fte rw a rd s , m em brane was w ashed 4  tim es fo r each 5 m inutes w ith  antib o d y 
w ash solution and rinsed 2 times each 2 m inutes w ith  ultra pure w ater.
8. B ands w ere vis u a lize d  b y  treating m em brane fo r 0 -6 0  m inutes w ith  5m l 
chrom ogen so lution (In v itro g e n ).
9. Re su ltant bands w ere d ig ita lize d  and qu antified b y  de nsito m e try analysis 
(G e lp ro  so ftw are ; Im age  Processing S o lu tio n s , N o r th  R e a d in g , M A ) .
5.10.2 Slot Blotting
F o r  slot b lo ttin g , this procedure was m a in ly  opted to detect the im m u n o  re a c tivity 
fo r the antibodies w h ic h  have lo w  se nsitivity to detect specific bands. 15 p L  equal 
am ounts o f  no rm al and D e l l 5 3 D  -affected protein extracts w ere b lo tte d , in 
triplicate, on a nitrocellulose m em brane ( H y b o n d  E C L ;  G E  H e alth c a re  L i f e  
Sciences, L ittle  C h a lfo n t, U K )  w ith  a slot b lo t apparatus (P R 6 0 0 ; H o e fe r  Scientific 
Instru m ents, San Fra n c is c o , C A ) .  B lo ts  w ere then incubated w ith  b lo c k in g  solution 
supplied in the k it (W e s te rn B re e ze ™  C h ro m o g e n ic  D e te c tio n  K i t ,  In v itro g e n . 
catalogue n o : W B 7 1 0 5 , W B 7 1 0 3 )  before the a d d itio n  2 p g /m l
Phosphoserine/threonine/tyrosine a n tib o d y (A b e a m ) fo r  2 hours at ro o m  
tem perature o r o ve rn ig h t at 4 ° C , fo llo w e d  b y  incu bation w ith  appropriate 
secondary a n tib o d y (an ti-m ou se/anti-rab bit). F in a lly , bands w ere vis u a lize d  w ith  
the enhanced ch rom ogenic substrate analysis system  supplied b y  the k it. F o r  
internal c o n tro l, the levels o f  p -ac tin  w ere exam ine d  b y  repeating the same 
procedure using a n ti-p -a c tin  (S ig m a ) and anti-m ouse secondary a n tib o d y  supplied 
in the k it.
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5.11 Antibodies
5.11.2 GNB3 Expression Analysis
F o r  G N B 3 e x p r e s s io n  analysis, fo u r d iffe re n t antibodies w ere e m p lo y e d . F o r  
detection o f  o ve ra ll expression, in c lu d in g  P3Y c o m ple xe s, G N B 3  p o ly c lo n a l 
a ntibody ( A 0 1 )  ( A b n o v a )  in a d ilu tio n  o f  1 :1 0 0 0  was used, raised against the fu ll 
length o f  the G p 3 protein w ith  G S T  tag. In  addition a G N B 3  m o n o c lo n al chicken 
specific a n tib o d y (peptide - M G E M E Q M K Q E A )  raised and a ffin ity  p u rifie d  at 
Le e d s U n iv e r s ity  has been used to detect the G N B 3  expression levels in  H u m a n  
C C , T T  cell protein extracts, norm al and rge tissue protein extracts. S o m e  
com m ercial antibodies w h ich  are available fro m  Santacru z biotech and C a lb io c h e m  
p ro ve d  no response to specific G N B 3  antigen.
5.11.3 MAPK Activity and Expression analysis
M A P K  ( E R K  1/2) activation was detected b y  using p o ly c lo n a l E R K  1/2 (phospho 
T 1 8 3 + Y 1 8 5 )  antib o d y solution (0 .5 4 p g /m l) (A b e a m ). E R K  1/2 (phospho 
T 1 8 3 + Y 1 8 5 )  a n tib o d y interacts o n ly  w ith  phosphorylated M A P K  iso form s E R K  1 
and 2 . F o r  determ ination o f  E R K  1/2 expression, E R K  1/2 p o lyc lo n a l antibodies 
(A b e a m ) have been used.
5.11.4 p-ARK (GRK2) Activity
p - A R K  ( G R K 2 )  activation has been determ ined b y  using p o lyc lo n a l G R K 2  
(phospho S 6 7 0 )  antib o d y solution (1 .5 p g / m l) (A b e a m ). G R K 2  (phospho S 6 7 0 ) 
interacts o n ly  w ith  phosphorylated species o f  p - A R K .
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5.11.5 Protein Phosphorylation Activity
T h e  entire cellular p ro te in pho sph o rylatio n status, was m easured b y  using 
0 .75 p g / m l m o noclon al phosphoserine/threonine/tyrosine a n tib o d y solution 
(A b e a m ) that specific binds to phosphorylated serine, threonine and tyrosine 
residues on rge affected and norm al tissues protein extracts as w e ll as h u m a n C C  
and T T  cell lines.
5.12 Enzyme Immuno Assays for cAMP & cGMP Level 
Determination
E n z y m e  im m u n o  assays w ere p erform ed  w ith  a com m ercial C y c lic  A M P / G M P  
E I A  K its  (C a y m a n  C h e m ic a ls ) in accordance to the instruction p ro to c o l (http:// 
w w w .c a y m a n c h e m .c o m ).
1 . F o r  the assay, 50 pi o f  each tissue sample and as w e ll as a standard, together w ith  
50 pi o f  cyclic A M P / G M P  tracer ( c G M P / c A M P  coupled to acetylcholinesterase) 
and 50 pi o f  a rabbit a nti-c yc lic  G M P  antiserum  was added to m icroplate w ells 
precoated w ith  m ouse m o n o c lo n al anti-rabbit im m u n o g lo b u lin  G  ( I g G )  antibodies.
2 . T h e  plate was incubated at ro o m  tem perature fo r  18 h.
3. W e lls  w ere em ptied and w ashed fiv e  tim es. S u bse qu e ntly, 200 pi o f  E llm a n 's  
reagent (ac e tylth io c h o lin e + 5 , 5 '-d ith io -b is -2 -n itro b e n zo ic  acid) w as added to the 
w ells.
4 . T h e  plate w as developed fo r 12 0  m inutes at a ro o m  tem perature in the d ark  using a 
ro ta ry shaker.
5. T h e  concentration o f  the p ro du ct (5 -th io -2 -n itro b e n zo ic  acid) w as assayed b y  
m easuring the absorbance at 4 1 2  n m  w ith  the use o f  a spectrophotom eter.
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E a c h  tissue sam ple, as w e ll as a standard was assessed in triplicates fo r 
qu antification o f  c A M P  and c G M P  levels. A s s a y s  were repeated tw ic e .
5.13 Imaging Analysis & Data presentation
C a lc u la tio n  o f  q u an tifie d  data and statistical analysis on resultant blots were 
perform ed b y  capturing the images in h igh  resolution T I F F  fo rm a t files using a 
charge-coupled-de vice camera ( A x i o C a m  M R c , C a rl Z e is s ). D e n s ito m e try  analysis 
o f  the im ages is done w ith  the com puter p ro g ra m  G e lp ro  (G e lp r o  S o ftw a re , San 
D ie g o , U S A ) .  c A M P / c G M P  E L I S A  based experim ents sh o w n are representative 
fo r a total o f  at least three experim ents in triplicates o f  sam ples. T h e  m icroplate 
w ells w ere read on an A n th o s  H T I I I  M ic ro p la te  R e a d e r (D e n le y  Instru m ents, 
B illing sh u rst) u tilis in g  its integral softw are to calculate results. A l l  the results are 
statistically p ro ve d  b y  calculating the appropriate standard deviation/error 
represented in the graphs
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Chapter VI
Our test o f truth is a reference to either a present or 
imaginedfuture mcgoritg in favour o f our view__
Oliver Wendell Holmes Jr. (1841 - 1935)
Chapter 6
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Chapter VII
Someone's boring me. 0 tfiink.it's me....
Dylan Thomas (1914 - 1953),
CHAPTER 7
APPENDIX
7.1 BUFFERS AND CHEMICAL LIST
T h e  fo llo w in g  list represents the com m ercial chem icals that w ere m a in ly  
e m p lo y e d . M a n u fa c tu re d  b uffers are listed under chapter 7 .1 .2 .
7.1.1 Consumables
• Antibody wash solution (In vitro gen # 46-7005)
• Chromogen solution
• Cyclic AMP EIA Kit
• Cyclic GMP EIA Kit
• Coomassie (Bradford) Protein Assay Kit
• Blocker/Diluent A
• Blocker/Diluent B
• Bovine serum albumin (BSA) standard
• ERK 1/ERK 2 antibody
• ERK 1/ERK 2 (phospho T183+Y185) antibody
• GNB3 polyclonal antibody (AO 1)
• GRK2 (phospho S670) antibody
• Halt® Phospatase inhibitor cocktail
• Halt® Protease inhibitor cocktail
• Hybind™ ECL™ Nitrocellulose membrane
• NuPage® 10% Bis-Tris Gel
(Invitrogen # SO-WOOl) 
(Caymanchem.#581001.1) 
(Caymanchem.#581022.1) 
(Pierce Biotech # 23200) 
(Invitrogen # 46-7003) 
(Invitrogen # 46-7004) 
(Pierce Biotech # 23209) 
(Abeam #ab 17942) 
(Abeam # ab50011)
(Abnova#H00002784A01) 
(Abeam# ab4473)
(Pierce Biotech. # 78420) 
(Pierce Biotech. #78415) 
(AmershamP# rpnd/98/i I) 
(Invitrogen # NP0301)
• NuPage® MES SDS page running buffer 20x (Invitrogen # NP0002)
• Novex® Sharp Pre- Stained protein Standard (Invitrogen # LC5625)
• NuPage® Transfer buffer 20x (Invitrogen # NP0005-1)
• Phosphoserine/threonine/tyrosine antibody (Abeam # ab 15556)
• RIPA Buffer (Pierce Biotech # 89901)
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Secondary antibody solution (mouse) (Invitrogen # 46-7006)
• Secondary antibody wash solution (rabbit) (Invitrogen # 46-7007)
• Western Breeze Immunodetecion Kit (Invitrogen # WB7103)
7.1.2 Manufactured buffers
Blocking solution: ultra filtered water, Blocker A  (Invitrogen) and Blocker B 
(Invitrogen), components blended in a ratio 7 : 2 : 1
7.1.3 A table of various parameters used for perfecting SDS-PAGE with the 
Invitrogen family of electrophoretic products.
As
sa
y
%
polyacrylamide
Well loading 
volume
Volt
age
Time
i 1 0 % 2 0 pl 80v 90min
2 1 0 % 2 0 pl 12 0 v 90min
3 2 0 % 15pl 30v 12 0 min
4 1 0 % 30pl 80v 60min
5 1 0 % 2 0 pl 80v 60min
6 1 0 % lOpl 80v 60min
A  table to summarise the discrete adjustments that were made to the immunoassay 
procedure when performing the western strip blots derived from two PVDF 
membranes.
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7.1.4 PVDF membrane blotting procedure
Im m u noassay
Stage
Strip  1
h e te ro zyg
ous
Strip  2 
rge
S trip  3 
rge
S trip  4  
rge
B lo c k in g Blocked Blocked Blocked Blocked
Stage at 4°C at 4°C at 4°C at 4°C
overnight overnig
ht
overnig
ht
overnig
ht
Initial rinsing A s  per A s  per A s  per A s  per
stage protocol protocol p rotocol p ro to co l
1 ° A B 1:500 1 :2 0 0 0 1:3000 1:5000
Incubation dilution dilution dilution dilution
stage at37°C at 37° C at 37°C at 37°C
for 120 for 120 for 120 for 120
minutes minutes minutes minutes
P o s t-1 ° A B A s  per A s  per A s  per A s  per
W a s h in g
stage
p rotocol protocol p rotocol p ro to co l
2 ° A B 37°C for 37° C 37° C 37°C
Incubation 60 for 60 for 60 for 60
stage minutes minutes minutes minutes
P o s t - 2 ° A B A s  per A s  per A s  per A s  per
W a s h in g
stage
p rotocol protocol p rotocol p ro to co l
F in a l rinsing A s  per A s  per A s  per A s  per
Stage p rotocol p rotocol p rotocol p rotocol
7.2 Cyclic AMP/ Cyclic GMP assay
C y c lic  A M P /  C y c lic  G M P  assay is the assay carried out to fin d  variations in the 
concentration o f  c A M P / c G M P  in the samples w h en com pared to standard c u rve . T h is  
assay was p e rfo rm e d  w ith  C a y m a n ’ s “ C y c lic  A M P / C y c lic  G M P  E I A  K i t ”  and according 
to its p ro to co l (A p p e n d ix  F o u r ) . T h e  c A M P / c G M P  in  sam ple com petes w ith  
c A M P / c G M P  tracer fo r  the secondary a n tib o d y w h ic h  com bines w ith  pre-coated m ouse 
m o noclon al p rim a ry  a n tib o d y. T h e  k it has C y c lic  A M P /  C y c lic  G M P  E I A  A n tis e ru m  (1
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v ia l / 10 0  d tn ), C y c lic  A M P / C y c l i c  G M P  A C h E  T ra c e r (1 via l / 10 0  d tn ), C y c lic  A M P /  
C y c lic  G M P  E I A  Standard (1 v ia l) , E I A  B u ffe r  Concentrate ( 1 0 X )  (2 via ls / 1 0 m l), W a s h  
B u ffe r  Concentrate ( 4 0 0 X )  (1 v ia l / 5 m l), T w e e n  20 (1 v ia l / 3 m l) , one M o u s e  A n t i ­
rabbit I g G  C o a te d  plate, one plate c o ve r, E llm a n ’ s Reag ent (3 via ls / 10 0  d tn ), A c e tic  
A n h y d r id e  (1 via l / 2 .5 m l) , K O H  (1 v ia l) , E I A  T ra c e r D y e  (1  v ia l) , E I A  A n tis e ru m  D y e  
(1 v ia l).
7.2.1 Principle of cayman cAMP/ cGMP assay
T h is  assay is an A C E ™  C o m p e titiv e  Im m u n o a s sa y, w here there is a com petition 
betw een free c A M P / c G M P  ( c A M P / c G M P  in sam ple) and a c A M P / c G M P  - 
acetylchotinesterase ( A C h E )  conjugate ( c A M P / c G M P  tracer) fo r a constant nu m ber o f  
c A M P / c G M P  -specific rabbit a ntibody b in d in g  sites. T h e  k it contains a 9 6 -w e ll plate 
w here each w e ll was pre-coated w ith  m ouse m o noclon al antib o d y w h ic h  serves as a 
p rim a ry  a n tib o d y in the assay. T h e  w ells w ere also coated w ith  a p ro prie ta ry solution o f  
proteins. T h e  E I A  antiserum  w ill act as a c A M P / c G M P  -specific rabbit secondary 
a n tib o d y that binds to p rim a ry  a n tib o d y coated on the w alls o f  w e ll. T h e  c A M P / c G M P  
tracer and the c A M P / c G M P  o f  sam ple com pete fo r the secondary a n tib o d y.
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O O. ♦ o ° * o X- ° r ° 
° * oV 5  ou
Y Y...Y  Y  Y Y  Y  Y Y Y
P la t e s  a re  p r e - c o a t e d  w i t h  m o u s e  m o n o c l o n a l  a n t i b o d y  
a n d  b lo c k e d  w i t h  a  p r o p r ie ta r y ' f o r m u la t io n  o f
1. I n c u b a t e  w i t h  tr a c e r ,  a n t i s e r u m ,  a n d  e i t h e r  s ta n d a r d  o r  u n k n o w n  
s a m p le .
p r o t e in s .
J I
^  4 $
T  T  I I
2 .  W a s h  to  r e m o v e  a ll  u n b o u n d  r e a g e n ts .
3 .  D e v e l o p  t h e  w e l l  w i t h  
Ell m a n  s R e a g e n t .
= Mouse Monoclonal Antibody
= Blocking Proteins
■ O = Acetylcholinesterase linked to
cAMP (Tracer)/cGMP (Tracer)
□— = Specific Antibody to cAMP/cGMP 
O = Free cAMP/cGMP
F i g .  S c h e m a tic  d ia g r a m  o f  th e  A C E ™  E n z y m e  Im m u n o a s s a y
P ic tu r e  a d a p te d  f r o m : C y c lic  A M P / C y c l i c  G M P  E I A  k it  m a n u a l [ O n l i n e ] . C a y m a n  
C h e m ic a ls . A v a ila b le  at
http://www.caymanchem.com/app/template/Product.vni/eatalog/581001/a/z. [A c c e s se d  o n
10 /09/2 0 0 8]
The cAMP tracer reacts with the ellman’s reagent and produces a distinct colour that
absorbs strongly at 412nm. The principle of cAMP was represented pictorially in Fig:
(2.3). So, the absorbance reading denotes directly the quantity of cAMP tracer bound to
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m ouse antib o d y and the reading is in d ire c tly propo rtio nal to the qu an tity o f  c A M P  in 
sam ple in  the w e ll. T h is  can be interpreted as the absorbance reading increases, the 
qu an tity o f  c A M P  tracer increases and the q u an tity o f  c A M P  in sam ple decreases. T h is  
can be represented as an equation as b e lo w :
A b so rb a n c e  oo [B o u n d  c A M P  Tra c e r] go 1/ [ c A M P / c G M P ]
T h e  c A M P / c G M P  standard curve was calculated b y  p lo ttin g  a graph betw een % B / B o  and 
c A M P / c G M P  concentrations o f  the standard. T h e  c A M P / c G M P  levels in samples w ere 
estimated b y  com paring the obtained readings against the standard cu rve .
7 .2 .2  Biochemistry of A C E ™  E I A  assay
Ele c tric  eel, Ele c tro p h o ru s electricus, contains electric organ w h ic h  produces A C h E  that 
has a capacity o f  h igh tu rn o ve r fo r  the h yd ro lysis o f  acetylcho line. T h is  A C h E  is 
c o va le n tly attached to a m olecule o f  analyte and act as a T ra c e r in im m unoassasy. 
E llm a n ’ s R e a g e n t, w h ic h  has acetylcholine and 5 ,5 ’ -d ith io -b is -(2 -n itro b e n zo ic  a c id ), can 
measure the a c tivity  o f  A C h E  and in turn the qu an tity o f  tracer that is b in d in g  to 
antibodies in the w e ll. A C h E  hydrlyses acetylcholine to th io c h o lin e , w h ic h  on non - 
e n zy m a tic  reaction w ith  5 ,5 ’ -d ith io -b is -(2 -n itro b e n zo ic  acid) produces 5 -th io -2 - 
n itro b e n zo ic  acid. It has a distinct y e llo w  c o lo u r and strong absorption at 4 1 2 n m . T h e  
bioche m istry o f  A C E ™  E I A  A s sa y s was represented in F ig u re  b e lo w .
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Acetyithiocholine
'OOC
■ s—\v / / " ° 2
COO'
5-thio-2-Nitrobenzoic Acid 
X_ r : 412 runmix
z: 13.600
Fig. Schematic diagram of reaction catalyzed by Acetylycholinesterase
Picture adapted from: Cyclic AMP/Cyclic GMP EIA kit manual [Online]. Cayman
Chemical. Available at
http://www.caymanchem.eom/app/template/Product.vin/catalog/581001/a/z. [Accessed on
10/09/2008].
As the amount of cAMP/cGMP tracer is constant and the amount of cAMP/cGMP in 
sample (free cAMP) varies, the amount of cAMP/cGMP that binds to rabbit antibody 
will be inversely proportional to the quantity of cAMP/cGMP of sample in the well. The 
cAMP/cGMP assay was carried without any acetylation.
Hemanth Tummala 103 PhD.
7.2.2.1 cAMP/cGMP standard curve
The cAMP/cGMP standard curve is the curve obtained by running assay with 
cAMP/cGMP standard. This standard curve is useful in estimating the quantities of 
cAMP/cGMP in the sample.
7.2.2.2 Preparation of reagents
The reagents EIA Buffer, Wash Buffer, cAMP/cGMP tracer, and cAMP/cGMP 
antiserum were prepared as per the requirements of the experiment.
1.2.2.3 EIA buffer preparation
The vial (10ml) of EIA buffer concentrate was diluted with 90ml of ultra pure water. The 
vial was rinsed well to remove any salts that may have precipitated.
7.2.2.4 Wash buffer preparation
The vial (5ml) of Wash Buffer concentrate was diluted at 1:400 dilutions with ultra pure 
water. Later Tween 20 was added around 0.5ml/L of wash buffer. The quantity of wash 
buffer prepared was based on usage in the experiment every time.
1.2.2.5 cAMP/cGMP AChE tracer
cAMP/cGMP tracer (lOOdtn) was diluted with 6ml of EIA buffer. Tracer dye was added 
to the reconstituted tracer at a final dilution of 1:100 (60pl of dye to 6ml tracer) and 
stored at 4°C in refrigerator.
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7.2.2.6 cAMP/cGMP antiserum
cAMP/cGMP Antiserum (lOOdtn) was diluted with 6ml of EIA buffer. Antiserum dye 
was added to the reconstituted antiserum at a final dilution of 1:100 (60pl of dye to 6ml 
tracer) and stored at 4°C in refrigerator.
1.2.2.1 cAMP/cGMP standard
cAMP/cGMP standard was diluted with 1ml of EIA buffer to make the concentration to 
3000pmol/ml. The standard was stored at 4°C.
7.2.3 Preparation of standard samples
Neatly labelled 8 eppendorf tubes were taken with 900pl of EIA Buffer in tube 1 and 
500pl of EIA Buffer in tubes 2-8. In tube 1, lOOpl of reconstituted standard 
(3000pmol/ml) was added and mixed thoroughly to make the concentration to 
300pmol/ml.
Tubes 1 2 3 4 5 6 7 8
Concentration
(pmol/ml) 300 150 75 37.5 18.8 9.4 4.7 2.3
Table showing the concentration in each tube due to serial dilution.
500pl of aliquot was taken fro tube 1 and serially diluted into tube 2 and mixed well. 
Again 500pl of the aliquot was taken form tube 2 and transferred into tube 3 and mixed
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thoroughly. This serial dilution was continued until tube 8, and 500pl of aliquot was 
removed and discarded from tube 8. The quantity of the aliquot in each tube was 500 pi. 
These diluted standards were with different concentrations (table 2.5) and were used 
immediately for the experiment.
7.3 ADDITIONAL DATA
Fig. -  BSA standard curve for protein quantification
Molecular modeling of GNB3 molecule 1B9X PDB ID in J vriend WHATIF 
program
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